Diagnoses of HIV Infection in the United States and Dependent Areas 2019: Tables

All Tables
Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 31,822 31,362 30,457 29,742 28,813
Female 7,392 7,520 7,306 7,071 6,897
Transgender male-to-femaleb 589 640 581 596 623
Transgender female-to-maleb 32 21 36 48 46
Additional gender identityc 10 12 13 14 19
Age at diagnosis (yr)
<13 142 0.3 128 0.2 104 0.2 89 0.2 61 0.1
13–14 26 0.3 25 0.3 26 0.3 20 0.2 21 0.3
15–19 1,766 8.4 1,710 8.1 1,777 8.4 1,715 8.1 1,640 7.8
20–24 7,278 32.1 6,917 31.0 6,478 29.4 6,100 28.0 5,927 27.4
25–29 7,571 33.8 7,958 34.7 7,717 33.1 7,710 32.8 7,341 31.2
30–34 5,439 25.1 5,644 25.9 5,644 25.7 5,672 25.7 5,673 25.3
35–39 4,233 20.8 4,213 20.3 4,274 20.2 4,213 19.6 4,104 18.9
40–44 3,374 16.8 3,244 16.5 2,967 15.2 2,968 15.1 2,964 14.9
45–49 3,297 15.9 3,049 14.6 2,929 14.0 2,766 13.4 2,565 12.6
50–54 2,991 13.4 2,847 13.1 2,640 12.4 2,467 11.8 2,301 11.2
55–59 1,882 8.7 1,881 8.6 1,873 8.5 1,841 8.4 1,827 8.4
60–64 995 5.2 1,080 5.6 1,087 5.5 1,040 5.1 1,100 5.3
≥65 851 1.8 859 1.7 877 1.7 870 1.7 874 1.6
Race/ethnicity
American Indian/Alaska Native 172 7.3 217 9.1 206 8.6 182 7.5 210 8.6
Asian 918 5.3 927 5.2 921 5.1 854 4.6 737 3.9
Black/African American 16,757 42.0 16,571 41.2 15,988 39.4 15,493 37.9 15,334 37.3
Hispanic/Latinod 10,329 18.4 10,619 18.5 10,476 17.9 10,540 17.7 10,120 16.7
Native Hawaiian/other Pacific Islander 66 11.9 40 7.1 52 9.0 64 10.9 66 11.1
White 10,068 5.1 9,770 4.9 9,562 4.8 9,309 4.7 9,013 4.6
Multiracial 1,535 23.4 1,411 20.9 1,188 17.1 1,029 14.5 918 12.6
Transmission categorye
Male adult or adolescentf
Male-to-male sexual contact 26,273 25,947 25,337 24,556 23,866
Injection drug use 1,295 1,203 1,301 1,407 1,375
Male-to-male sexual contact and injection drug use 1,499 1,498 1,421 1,408 1,457
Heterosexual contactg 3,249 3,275 2,913 2,903 2,685
Perinatalh 14 8 12 14 14
Otheri 17 16 22 21 23
Subtotal 32,347 24.7 31,948 24.2 31,005 23.3 30,308 22.6 29,419 21.8
Female adult or adolescentf
Injection drug use 1,033 1,000 1,053 1,084 1,106
Heterosexual contactg 6,298 6,437 6,198 5,958 5,787
Perinatalh 18 37 26 24 21
Otheri 7 6 7 8 5
Subtotal 7,356 5.4 7,479 5.4 7,284 5.2 7,074 5.0 6,918 4.9
Child (<13 yrs at diagnosis)
Perinatal 111 102 86 67 49
Otheri 31 26 18 22 12
Subtotal 142 0.3 128 0.2 104 0.2 89 0.2 61 0.1
Region of residencej
Northeast 6,466 11.5 6,216 11.1 6,009 10.7 5,570 9.9 5,275 9.4
Midwest 5,239 7.7 5,184 7.6 5,104 7.5 4,947 7.2 4,759 7.0
South 20,395 16.9 20,284 16.6 19,722 16.0 19,412 15.6 19,135 15.2
West 7,745 10.2 7,871 10.3 7,558 9.8 7,542 9.7 7,229 9.2
Total 39,845 12.4 39,555 12.2 38,393 11.8 37,471 11.5 36,398 11.1

Note: Numbers less than 12 should be interpreted with caution.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b”Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dHispanic/Latino persons can be of any race.
eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
fData presented based on sex at birth and include transgender persons.
gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
iIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
jData are based on residence at time of diagnosis of HIV infection.

Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 32,292 31,808 30,826 30,109 29,133
Female 7,504 7,625 7,400 7,152 6,978
Transgender male-to-femaleb 593 642 583 597 625
Transgender female-to-maleb 32 21 36 48 46
Additional gender identityc 10 12 13 14 19
Age at diagnosis (yr)
<13 142 0.3 128 0.2 104 0.2 89 0.2 61 0.1
13–14 26 0.3 25 0.3 26 0.3 20 0.2 21 0.2
15–19 1,773 8.3 1,721 8.0 1,790 8.4 1,731 8.1 1,646 7.7
20–24 7,359 32.1 6,991 30.9 6,543 29.3 6,158 27.9 5,981 27.3
25–29 7,668 33.8 8,027 34.7 7,782 33.0 7,787 32.8 7,396 31.1
30–34 5,500 25.2 5,710 25.9 5,708 25.8 5,730 25.7 5,731 25.3
35–39 4,303 20.9 4,285 20.4 4,327 20.2 4,247 19.5 4,143 18.9
40–44 3,439 16.9 3,301 16.6 3,004 15.2 3,012 15.1 3,004 14.9
45–49 3,364 16.0 3,108 14.7 2,970 14.0 2,810 13.4 2,602 12.6
50–54 3,049 13.5 2,893 13.1 2,692 12.5 2,517 11.9 2,329 11.2
55–59 1,915 8.7 1,930 8.7 1,907 8.6 1,868 8.4 1,863 8.4
60–64 1,010 5.2 1,105 5.6 1,108 5.5 1,060 5.2 1,123 5.4
≥65 883 1.8 884 1.8 897 1.7 891 1.7 901 1.6
Race/ethnicity
American Indian/Alaska Native 172 217 206 182 210
Asian 922 928 924 858 743
Black/African American 16,766 16,577 15,992 15,500 15,340
Hispanic/Latinod 10,896 11,157 10,926 10,970 10,502
Native Hawaiian/other Pacific Islander 69 46 55 66 70
White 10,070 9,772 9,566 9,313 9,018
Multiracial 1,536 1,411 1,189 1,031 918
Transmission categorye
Male adult or adolescentf
Male-to-male sexual contact 26,585 26,244 25,580 24,819 24,084
Injection drug use 1,348 1,241 1,333 1,432 1,397
Male-to-male sexual contact
and injection drug use
1,522 1,510 1,432 1,420 1,468
Heterosexual contactg 3,335 3,377 2,997 2,970 2,754
Perinatalh 14 8 12 14 14
Otheri 17 16 22 21 23
Subtotal 32,821 24.8 32,396 24.2 31,376 23.3 30,676 22.6 29,741 21.8
Female adult or adolescentf
Injection drug use 1,040 1,011 1,062 1,086 1,111
Heterosexual contactg 6,402 6,530 6,283 6,037 5,863
Perinatalh 18 37 26 24 21
Otheri 7 6 7 8 5
Subtotal 7,468 5.4 7,584 5.4 7,378 5.2 7,155 5.0 6,999 4.9
Child (<13 yrs at diagnosis)
Perinatal 111 102 86 67 49
Otheri 31 26 18 22 12
Subtotal 142 0.3 128 0.2 104 0.2 89 0.2 61 0.1
Region of residencej
Northeast 6,466 11.5 6,216 11.1 6,009 10.7 5,570 9.9 5,275 9.4
Midwest 5,239 7.7 5,184 7.6 5,104 7.5 4,947 7.2 4,759 7.0
South 20,395 16.9 20,284 16.6 19,722 16.0 19,412 15.6 19,135 15.2
West 7,745 10.2 7,871 10.3 7,558 9.8 7,542 9.7 7,229 9.2
U.S. dependent areas 586 15.1 553 14.5 465 12.5 449 12.5 403 11.2
Total 40,431 12.5 40,108 12.3 38,858 11.8 37,920 11.5 36,801 11.1

Note: Numbers less than 12 should be interpreted with caution.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dHispanic/Latino persons can be of any race.
eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
fData presented based on sex at birth and include transgender persons.
gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
iIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
jData are based on residence at time of diagnosis of HIV infection.

Table 2a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2019—United States
American Indian/Alaska Native Asian Black/African American Hispanic/Latinoa Native Hawaiian/other Pacific Islander White Multiracial Total
No. Rateb No. Rateb No. Rateb No. Rateb No. Rateb No. Rateb No. Rateb No. Rateb
Gender
Male 161 626 11,208 8,648 52 7,419 699 28,813
Female 44 99 3,812 1,237 9 1,498 198 6,897
Transgender male-to-femalec 5 11 289 219 5 80 14 623
Transgender female-to-malec 0 1 19 12 0 11 3 46
Additional gender identityd 0 0 6 4 0 5 4 19
Age at diagnosis (yr)
<13 1 0.2 5 0.2 35 0.5 8 0.1 0 0.0 7 0.0 5 0.2 61 0.1
13–14 0 0.0 0 0.0 14 1.2 6 0.3 0 0.0 1 0.0 0 0.0 21 0.3
15–19 9 5.1 22 2.0 931 32.1 441 8.7 2 4.8 189 1.7 46 6.1 1,640 7.8
20–24 37 20.4 102 8.1 2,978 97.3 1,647 34.0 8 18.6 1,000 8.6 155 23.0 5,927 27.4
25–29 39 19.4 146 9.3 3,140 89.9 2,167 43.9 23 45.2 1,623 12.8 203 34.8 7,341 31.2
30–34 26 14.9 119 7.2 2,225 73.5 1,710 37.3 12 23.1 1,420 11.4 161 36.5 5,673 25.3
35–39 38 23.9 97 6.1 1,463 52.6 1,273 28.2 9 18.3 1,128 9.2 96 25.5 4,104 18.9
40–44 19 13.4 57 3.9 1,091 43.1 926 22.3 5 12.3 800 7.1 66 21.4 2,964 14.9
45–49 12 8.4 74 5.2 939 36.6 688 18.0 1 2.7 794 6.5 57 20.7 2,565 12.6
50–54 16 11.0 47 3.9 867 34.2 566 17.1 4 11.4 756 5.8 45 18.9 2,301 11.2
55–59 7 4.5 31 2.8 719 27.5 328 11.5 1 2.9 694 4.7 47 20.0 1,827 8.4
60–64 3 2.1 19 1.9 511 21.8 202 9.1 1 3.5 348 2.4 16 7.8 1,100 5.3
≥65 3 1.0 18 0.7 421 8.5 158 3.4 0 0.0 253 0.6 21 4.9 874 1.6
Transmission categorye
   Male adult or adolescentf
Male-to-male sexual contact 126 573 9,122 7,613 52 5,802 577 23,866
Injection drug use 15 14 408 304 1 599 33 1,375
Male-to-male sexual contact
and injection drug use
15 13 298 394 2 683 52 1,457
Heterosexual contactg 8 31 1,644 544 2 407 49 2,685
Perinatalh 0 1 8 3 0 1 0 14
Otheri 0 2 9 6 0 6 1 23
   Subtotal 165 16.9 635 8.3 11,489 71.7 8,864 37.5 57 23.2 7,498 8.9 711 30.1 29,419 21.8
   Female adult or adolescentf
Injection drug use 18 6 323 170 0 549 40 1,106
Heterosexual contactg 27 90 3,471 1,074 9 954 162 5,787
Perinatalh 0 0 15 4 0 2 0 21
Otheri 0 0 1 0 0 2 0 5
   Subtotal 44 4.3 97 1.1 3,810 21.3 1,248 5.3 9 3.7 1,508 1.7 202 8.1 6,918 4.9
   Child (<13 yrs at diagnosis)
Perinatal 1 3 28 7 0 7 3 49
Otheri 0 2 7 1 0 0 2 12
   Subtotal 1 0.2 5 0.2 35 0.5 8 0.1 0 0.0 7 0.0 5 0.2 61 0.1
Region of residencej
Northeast 5 3.9 137 3.6 2,155 34.0 1,654 19.9 1 4.6 1,125 3.1 198 20.1 5,275 9.4
Midwest 33 7.9 74 3.1 2,269 31.6 664 12.0 11 30.0 1,571 3.1 137 9.9 4,759 7.0
South 64 7.9 195 4.3 9,638 40.1 4,657 20.2 14 14.4 4,128 5.8 439 18.1 19,135 15.2
West 108 10.0 331 4.0 1,272 35.2 3,145 13.3 40 9.1 2,189 5.6 144 5.8 7,229 9.2
Total 210 8.6 737 3.9 15,334 37.3 10,120 16.7 66 11.1 9,013 4.6 918 12.6 36,398 11.1

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

aHispanic/Latino persons can be of any race.
bRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
c“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
dAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
fData presented based on sex at birth and include transgender persons.
gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
iIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
jData are based on residence at time of diagnosis of HIV infection.

Table 2b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2019—United States and 6 dependent areas
American Indian/Alaska Native Asian Black/African American Hispanic/Latinoa Native Hawaiian/other Pacific Islander White Multiracial Total
No. No. No. No. No. No. No. No.
Gender
Male 161 632 11,212 8,950 55 7,424 699 29,133
Female 44 99 3,814 1,315 10 1,498 198 6,978
Transgender male-to-femaleb 5 11 289 221 5 80 14 625
Transgender female-to-maleb 0 1 19 12 0 11 3 46
Additional gender identityc 0 0 6 4 0 5 4 19
Age at diagnosis (yr)
<13 1 5 35 8 0 7 5 61
13–14 0 0 14 6 0 1 0 21
15–19 9 22 931 447 2 189 46 1,646
20–24 37 102 2,979 1,699 9 1,000 155 5,981
25–29 39 150 3,140 2,217 24 1,623 203 7,396
30–34 26 120 2,225 1,764 12 1,423 161 5,731
35–39 38 98 1,463 1,311 9 1,128 96 4,143
40–44 19 57 1,092 964 6 800 66 3,004
45–49 12 74 940 723 1 795 57 2,602
50–54 16 47 868 592 5 756 45 2,329
55–59 7 31 720 363 1 694 47 1,863
60–64 3 19 511 225 1 348 16 1,123
≥65 3 18 422 183 0 254 21 901
Transmission categoryd
    Male adult or adolescente
Male-to-male sexual contact 126 578 9,123 7,820 54 5,805 577 24,084
Injection drug use 15 14 409 326 1 599 33 1,397
 Male-to-male sexual contact and injection drug use 15 14 298 403 3 684 52 1,468
Heterosexual contactf 8 31 1,646 611 2 408 49 2,754
Perinatalg 0 1 8 3 0 1 0 14
Otherh 0 2 9 6 0 6 1 23
   Subtotal 165 641 11,493 9,168 60 7,503 711 29,741
   Female adult or adolescente
Injection drug use 18 6 323 175 0 549 40 1,111
Heterosexual contactf 27 90 3,473 1,147 10 954 162 5,863
Perinatalg 0 0 15 4 0 2 0 21
Otherh 0 0 1 0 0 2 0 5
   Subtotal 44 97 3,812 1,326 10 1,508 202 6,999
   Child (<13 yrs at diagnosis)
Perinatal 1 3 28 7 0 7 3 49
Otherh 0 2 7 1 0 0 2 12
   Subtotal 1 5 35 8 0 7 5 61
Region of residencei
Northeast 5 137 2,155 1,654 1 1,125 198 5,275
Midwest 33 74 2,269 664 11 1,571 137 4,759
South 64 195 9,638 4,657 14 4,128 439 19,135
West 108 331 1,272 3,145 40 2,189 144 7,229
U.S. dependent areas 0 6 6 382 4 5 0 403
Total 210 743 15,340 10,502 70 9,018 918 36,801

Note: Numbers less than 12 should be interpreted with caution.

aHispanic/Latino persons can be of any race.
b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
eData presented based on sex at birth and includes transgender persons.
fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
iData are based on residence at time of diagnosis of HIV infection.

Table 3a. Diagnoses of HIV infection among adults and adolescents, by year of diagnosis, sex at birth, and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
Age at diagnosis (yr)
13–14 12 0.3 9 0.2 13 0.3 11 0.3 12 0.3
15–19 1,513 14.0 1,461 13.5 1,531 14.2 1,471 13.7 1,437 13.4
20–24 6,458 55.5 6,179 53.8 5,701 50.4 5,382 48.2 5,201 47.0
25–29 6,597 57.9 6,900 59.2 6,738 56.7 6,759 56.4 6,398 53.3
30–34 4,452 41.0 4,610 41.9 4,630 41.8 4,719 42.2 4,708 41.5
35–39 3,286 32.4 3,249 31.3 3,344 31.6 3,286 30.5 3,209 29.5
40–44 2,566 25.7 2,477 25.4 2,227 22.9 2,185 22.3 2,216 22.4
45–49 2,537 24.7 2,275 22.0 2,165 20.9 2,047 20.0 1,890 18.7
50–54 2,252 20.6 2,123 19.8 1,980 18.9 1,808 17.6 1,677 16.6
55–59 1,348 12.8 1,308 12.3 1,313 12.3 1,297 12.2 1,317 12.4
60–64 700 7.7 734 7.9 755 7.9 720 7.4 748 7.6
≥65 626 3.0 623 2.9 608 2.7 623 2.7 606 2.5
Race/ethnicity
American Indian/Alaska Native 125 13.3 176 18.6 161 16.8 153 15.8 165 16.9
Asian 787 11.4 777 10.9 799 10.9 748 10.0 635 8.3
Black/African American 12,412 80.6 12,179 78.2 11,737 74.6 11,521 72.6 11,489 71.7
Hispanic/Latinob 8,999 41.6 9,282 41.9 9,149 40.4 9,173 39.6 8,864 37.5
Native Hawaiian/other Pacific Islander 60 26.5 34 14.7 43 18.2 59 24.5 57 23.2
White 8,687 10.4 8,341 9.9 8,130 9.7 7,842 9.3 7,498 8.9
Multiracial 1,277 62.3 1,159 54.5 986 44.8 812 35.6 711 30.1
Region of residencec
Northeast 5,040 21.9 4,803 20.8 4,664 20.2 4,344 18.8 4,128 17.9
Midwest 4,259 15.3 4,211 15.1 4,139 14.8 4,012 14.3 3,786 13.5
South 16,201 33.1 16,086 32.4 15,582 31.1 15,411 30.4 15,252 29.8
West 6,847 22.0 6,848 21.7 6,620 20.7 6,541 20.3 6,253 19.2
Subtotal 32,347 24.7 31,948 24.2 31,005 23.3 30,308 22.6 29,419 21.8
Female adult or adolescent
   Age at diagnosis (yr)
13–14 14 0.3 16 0.4 13 0.3 9 0.2 9 0.2
15–19 253 2.5 249 2.4 246 2.4 244 2.4 203 2.0
20–24 820 7.4 738 6.8 777 7.2 718 6.7 726 6.9
25–29 974 8.8 1,058 9.4 979 8.6 951 8.3 943 8.2
30–34 987 9.2 1,034 9.5 1,014 9.3 953 8.7 965 8.7
35–39 947 9.3 964 9.3 930 8.8 927 8.6 895 8.2
40–44 808 8.0 767 7.7 740 7.5 783 7.9 748 7.5
45–49 760 7.3 774 7.3 764 7.2 719 6.9 675 6.5
50–54 739 6.5 724 6.5 660 6.1 659 6.2 624 6.0
55–59 534 4.8 573 5.1 560 5.0 544 4.8 510 4.5
60–64 295 3.0 346 3.4 332 3.2 320 3.0 352 3.3
≥65 225 0.8 236 0.9 269 1.0 247 0.8 268 0.9
   Race/ethnicity
American Indian/Alaska Native 45 4.6 41 4.1 45 4.5 29 2.9 44 4.3
Asian 120 1.5 142 1.8 116 1.4 101 1.2 97 1.1
Black/African American 4,258 24.7 4,314 24.7 4,194 23.8 3,920 22.1 3,810 21.3
Hispanic/Latinob 1,317 6.2 1,319 6.0 1,311 5.9 1,357 5.9 1,248 5.3
Native Hawaiian/other Pacific Islander 6 2.7 6 2.6 8 3.4 5 2.1 9 3.7
White 1,364 1.6 1,412 1.6 1,416 1.6 1,451 1.7 1,508 1.7
Multiracial 246 11.2 245 10.8 194 8.3 211 8.7 202 8.1
   Region of residencec
Northeast 1,400 5.7 1,400 5.7 1,336 5.4 1,218 4.9 1,140 4.6
Midwest 953 3.3 943 3.3 947 3.3 920 3.2 964 3.3
South 4,130 8.0 4,134 7.9 4,076 7.7 3,953 7.4 3,848 7.1
West 873 2.8 1,002 3.1 925 2.9 983 3.0 966 2.9
   Subtotal 7,356 5.4 7,479 5.4 7,284 5.2 7,074 5.0 6,918 4.9
Total 39,703 14.8 39,427 14.6 38,289 14.1 37,382 13.6 36,337 13.2

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population.
bHispanic/Latino persons can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 3b. Diagnoses of HIV infection among adults and adolescents, by year of diagnosis, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
   Age at diagnosis (yr)
13–14 12 0.3 9 0.2 13 0.3 11 0.3 12 0.3
15–19 1,518 13.9 1,470 13.4 1,540 14.1 1,485 13.7 1,443 13.3
20–24 6,529 55.4 6,247 53.8 5,761 50.4 5,432 48.1 5,250 46.9
25–29 6,682 58.0 6,963 59.1 6,791 56.6 6,829 56.4 6,447 53.2
30–34 4,506 41.0 4,667 42.1 4,687 41.9 4,770 42.3 4,757 41.5
35–39 3,345 32.6 3,303 31.5 3,385 31.6 3,316 30.5 3,243 29.5
40–44 2,615 25.9 2,518 25.5 2,257 23.0 2,221 22.5 2,242 22.4
45–49 2,589 24.9 2,319 22.1 2,191 20.9 2,077 20.0 1,917 18.8
50–54 2,296 20.8 2,160 19.9 2,020 19.0 1,846 17.8 1,699 16.7
55–59 1,369 12.8 1,343 12.5 1,336 12.4 1,316 12.2 1,340 12.5
60–64 714 7.8 752 8.0 771 8.0 735 7.5 766 7.7
≥65 646 3.0 645 2.9 624 2.7 638 2.7 625 2.6
   Race/ethnicity
American Indian/Alaska Native 125 176 161 153 165
Asian 791 778 802 752 641
Black/African American 12,417 12,185 11,739 11,528 11,493
Hispanic/Latinob 9,459 9,715 9,509 9,522 9,168
Native Hawaiian/other Pacific Islander 63 40 46 61 60
White 8,689 8,343 8,132 7,846 7,503
Multiracial 1,277 1,159 987 814 711
   Region of residencec
Northeast 5,040 21.9 4,803 20.8 4,664 20.2 4,344 18.8 4,128 17.9
Midwest 4,259 15.3 4,211 15.1 4,139 14.8 4,012 14.3 3,786 13.5
South 16,201 33.1 16,086 32.4 15,582 31.1 15,411 30.4 15,252 29.8
West 6,847 22.0 6,848 21.7 6,620 20.7 6,541 20.3 6,253 19.2
U.S. dependent areas 474 30.4 448 29.2 371 24.5 368 25.0 322 21.8
   Subtotal 32,821 24.8 32,396 24.2 31,376 23.3 30,676 22.6 29,741 21.8
Female adult or adolescent
   Age at diagnosis (yr)
13–14 14 0.3 16 0.4 13 0.3 9 0.2 9 0.2
15–19 255 2.4 251 2.4 250 2.4 246 2.4 203 1.9
20–24 830 7.4 744 6.8 782 7.2 726 6.7 731 6.8
25–29 986 8.8 1,064 9.3 991 8.6 958 8.2 949 8.2
30–34 994 9.1 1,043 9.5 1,021 9.3 960 8.7 974 8.7
35–39 958 9.3 982 9.3 942 8.8 931 8.6 900 8.2
40–44 824 8.0 783 7.8 747 7.5 791 7.9 762 7.5
45–49 775 7.3 789 7.4 779 7.3 733 6.9 685 6.6
50–54 753 6.6 733 6.5 672 6.1 671 6.3 630 6.0
55–59 546 4.8 587 5.1 571 5.0 552 4.8 523 4.6
60–64 296 2.9 353 3.4 337 3.2 325 3.0 357 3.3
≥65 237 0.9 239 0.9 273 1.0 253 0.9 276 0.9
   Race/ethnicity
American Indian/Alaska Native 45 41 45 29 44
Asian 120 142 116 101 97
Black/African American 4,262 4,314 4,196 3,920 3,812
Hispanic/Latinob 1,424 1,424 1,401 1,438 1,326
Native Hawaiian/other Pacific Islander 6 6 8 5 10
White 1,364 1,412 1,418 1,451 1,508
Multiracial 247 245 194 211 202
   Region of residencec
Northeast 1,400 5.7 1,400 5.7 1,336 5.4 1,218 4.9 1,140 4.6
Midwest 953 3.3 943 3.3 947 3.3 920 3.2 964 3.3
South 4,130 8.0 4,134 7.9 4,076 7.7 3,953 7.4 3,848 7.1
West 873 2.8 1,002 3.1 925 2.9 983 3.0 966 2.9
U.S. dependent areas 112 6.5 105 6.1 94 5.6 81 4.9 81 4.9
Subtotal 7,468 5.4 7,584 5.4 7,378 5.2 7,155 5.0 6,999 4.9
Total 40,289 14.9 39,980 14.6 38,754 14.1 37,831 13.6 36,740 13.2

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
bHispanic/Latino persons can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 4a. Diagnoses of HIV infection among transgender adults and adolescents, by year of diagnosis and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-female adult or adolescenta
Age at diagnosis (yr)
13–14 0 0 0 0 0
15–19 65 56 53 36 35
20–24 158 188 141 155 158
25–29 166 179 164 175 156
30–34 73 88 106 92 129
35–39 53 64 52 68 57
40–44 22 26 28 33 40
45–49 27 15 18 22 20
50–54 18 9 8 6 16
55–59 5 8 6 5 7
60–64 2 3 5 2 4
≥65 0 3 0 2 1
Race/ethnicity
American Indian/Alaska Native 4 3 2 10 5
Asian 14 7 16 10 11
Black/African American 288 316 282 279 289
Hispanic/Latinob 216 217 194 214 219
Native Hawaiian/other Pacific Islander 3 2 3 3 5
White 35 55 66 54 80
Multiracial 29 39 18 26 14
Region of residencec
Northeast 138 144 100 111 102
Midwest 91 88 91 94 80
South 252 280 262 256 270
West 108 127 128 135 171
Subtotal 589 639 581 596 623
Transgender female-to-male adult or adolescenta
Age at diagnosis (yr)
13–14 0 0 0 0 0
15–19 2 1 3 2 0
20–24 5 4 8 9 11
25–29 7 5 16 18 19
30–34 7 3 3 8 12
35–39 3 4 3 5 2
40–44 5 1 0 4 0
45–49 2 2 2 1 2
50–54 1 1 0 1 0
55–59 0 0 1 0 0
60–64 0 0 0 0 0
≥65 0 0 0 0 0
Race/ethnicity
American Indian/Alaska Native 1 0 0 0 0
Asian 0 1 3 0 1
Black/African American 13 5 12 19 19
Hispanic/Latinob 9 6 7 10 12
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 7 6 11 17 11
Multiracial 2 3 3 2 3
Region of residencec
Northeast 4 1 6 7 5
Midwest 9 5 9 7 6
South 14 6 13 16 19
West 5 9 8 18 16
Subtotal 32 21 36 48 46
Total 621 660 617 644 669

Note: Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bHispanic/Latino persons can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 4b. Diagnoses of HIV infection among transgender adults and adolescents, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-female adult or adolescenta
Age at diagnosis (yr)
13–14 0 0 0 0 0
15–19 66 56 53 36 35
20–24 158 189 142 155 159
25–29 168 179 165 175 157
30–34 74 89 106 92 129
35–39 53 64 52 69 57
40–44 22 26 28 33 40
45–49 27 15 18 22 20
50–54 18 9 8 6 16
55–59 5 8 6 5 7
60–64 2 3 5 2 4
≥65 0 3 0 2 1
Race/ethnicity
American Indian/Alaska Native 4 3 2 10 5
Asian 14 7 16 10 11
Black/African American 288 316 282 279 289
Hispanic/Latinob 220 219 196 215 221
Native Hawaiian/other Pacific Islander 3 2 3 3 5
White 35 55 66 54 80
Multiracial 29 39 18 26 14
Region of residencec
Northeast 138 144 100 111 102
Midwest 91 88 91 94 80
South 252 280 262 256 270
West 108 127 128 135 171
US dependent areas 4 2 2 1 2
Subtotal 593 641 583 597 625
Transgender female-to-male adult or adolescenta
Age at diagnosis (yr)
13–14 0 0 0 0 0
15–19 2 1 3 2 0
20–24 5 4 8 9 11
25–29 7 5 16 18 19
30–34 7 3 3 8 12
35–39 3 4 3 5 2
40–44 5 1 0 4 0
45–49 2 2 2 1 2
50–54 1 1 0 1 0
55–59 0 0 1 0 0
60–64 0 0 0 0 0
≥65 0 0 0 0 0
Race/ethnicity
American Indian/Alaska Native 1 0 0 0 0
Asian 0 1 3 0 1
Black/African American 13 5 12 19 19
Hispanic/Latinob 9 6 7 10 12
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 7 6 11 17 11
Multiracial 2 3 3 2 3
Region of residencec
Northeast 4 1 6 7 5
Midwest 9 5 9 7 6
South 14 6 13 16 19
West 5 9 8 18 16
US dependent areas 0 0 0 0 0
Subtotal 32 21 36 48 46
Total 625 662 619 645 671

Note: Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bHispanic/Latino persons can be of any race.
cData are based on residence at time of diagnosis of HIV infection.

Table 5a. Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States
Male-to-male sexual contact Male-to-male sexual contact and injection drug use
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 4 2 2 7 7 1 0 0 0 1
20–24 30 24 18 25 26 0 4 3 2 3
25–29 21 37 32 22 29 1 5 6 7 6
30–34 16 30 18 20 18 0 3 6 5 1
35–39 12 11 15 10 19 3 2 1 2 2
40–44 6 14 12 9 6 0 0 2 1 0
45–49 5 6 6 7 6 0 0 1 3 1
50–54 5 5 8 6 9 0 1 0 1 1
55–59 4 3 2 3 5 0 0 0 0 0
60–64 0 3 2 2 2 0 0 1 0 0
≥65 0 1 1 3 0 0 1 1 0 0
Region of residencea
Northeast 3 7 2 5 5 0 0 0 0 0
Midwest 9 12 12 13 10 0 1 3 5 3
South 30 32 28 20 41 1 6 10 4 3
West 60 84 75 75 71 4 10 8 13 9
Total 102 135 116 113 126 6 16 21 22 15
Asian
Age at diagnosis (yr)
13–14 1 0 0 1 0 0 0 0 0 0
15–19 21 19 23 22 19 0 1 0 0 0
20–24 118 109 148 106 91 3 3 2 1 3
25–29 169 155 152 165 130 4 2 4 4 2
30–34 105 123 110 119 93 3 3 5 2 5
35–39 72 78 90 71 76 3 1 1 2 1
40–44 81 86 72 61 44 4 1 1 1 0
45–49 62 51 67 57 52 2 1 3 1 1
50–54 34 31 34 23 34 1 1 0 0 0
55–59 15 18 19 19 18 0 0 0 0 0
60–64 4 8 9 11 7 0 0 0 0 0
≥65 5 11 7 10 9 0 1 0 0 0
Region of residencea
Northeast 110 136 128 130 106 3 3 3 1 3
Midwest 82 61 78 67 53 4 4 1 0 1
South 143 142 145 162 144 4 1 1 2 4
West 352 349 380 305 270 10 7 12 8 5
Total 687 689 731 665 574 20 14 15 12 13
Black/African American
Age at diagnosis (yr)
13–14 8 3 4 7 8 0 0 0 0 0
15–19 827 782 836 788 781 15 16 10 9 11
20–24 2,884 2,784 2,506 2,383 2,369 60 53 40 46 39
25–29 2,400 2,502 2,431 2,457 2,328 49 70 66 76 83
30–34 1,167 1,187 1,306 1,253 1,409 38 50 46 51 64
35–39 704 707 737 729 749 33 32 34 25 33
40–44 477 443 421 432 456 19 15 17 17 20
45–49 447 371 349 350 340 21 18 13 9 17
50–54 346 336 323 307 283 14 12 23 18 14
55–59 204 204 205 198 203 15 10 11 10 10
60–64 85 93 114 100 114 5 8 5 6 5
≥65 79 66 65 77 81 4 4 4 4 3
Region of residencea
Northeast 1,206 1,151 1,160 1,093 1,124 32 34 37 50 38
Midwest 1,546 1,598 1,521 1,470 1,427 41 61 45 51 46
South 6,059 5,886 5,792 5,676 5,766 164 153 135 127 164
West 814 844 822 842 805 38 41 51 43 51
Total 9,626 9,478 9,296 9,081 9,122 274 289 268 270 298
Hispanic/Latinob
Age at diagnosis (yr)
13–14 1 2 5 0 2 0 0 0 0 0
15–19 348 342 356 345 378 16 14 12 11 8
20–24 1,641 1,568 1,447 1,448 1,399 76 83 70 68 68
25–29 1,683 1,896 1,847 1,906 1,772 96 91 101 117 96
30–34 1,242 1,375 1,377 1,375 1,345 77 81 75 61 68
35–39 938 962 964 951 930 48 45 57 47 62
40–44 589 630 612 587 625 33 38 24 29 37
45–49 556 487 532 509 467 25 17 21 22 20
50–54 367 372 355 347 350 10 20 16 21 19
55–59 176 161 183 202 186 6 7 9 5 9
60–64 62 79 74 85 90 3 5 4 4 4
≥65 61 52 74 67 71 2 3 2 1 3
Region of residencea
Northeast 1,301 1,238 1,270 1,161 1,136 59 56 40 53 55
Midwest 504 502 512 523 505 29 29 28 29 35
South 3,414 3,602 3,570 3,619 3,460 159 167 163 143 159
West 2,445 2,584 2,474 2,520 2,513 144 150 160 162 145
Total 7,663 7,926 7,826 7,823 7,613 391 401 390 387 394
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 2 1 1 3 1 0 0 0 0 0
20–24 9 1 9 7 7 0 0 0 2 0
25–29 11 7 9 10 19 0 2 0 1 0
30–34 10 4 8 13 10 0 2 0 1 1
35–39 7 7 2 8 6 1 0 1 0 1
40–44 2 3 5 2 4 0 0 0 0 0
45–49 5 1 1 2 1 0 0 0 0 0
50–54 5 2 1 1 3 0 0 0 0 0
55–59 2 0 0 4 1 0 0 0 0 0
60–64 0 0 0 1 1 0 0 0 0 0
≥65 0 1 0 1 0 0 1 0 0 0
Region of residencea
Northeast 1 3 3 2 1 0 1 0 0 0
Midwest 1 1 2 2 6 0 0 0 0 0
South 15 5 6 10 13 1 0 0 0 0
West 35 18 25 37 32 0 4 1 4 2
Total 52 26 36 51 52 1 5 1 4 2
White
Age at diagnosis (yr)
13–14 1 0 1 0 1 0 0 0 0 0
15–19 142 151 165 169 130 16 18 12 10 14
20–24 919 862 920 799 737 102 92 82 69 66
25–29 1,213 1,188 1,196 1,101 1,097 156 154 157 164 157
30–34 976 941 868 940 885 126 127 119 132 142
35–39 734 669 723 649 661 96 81 94 110 104
40–44 691 610 489 516 458 53 66 60 51 64
45–49 742 709 609 558 466 54 54 56 45 50
50–54 797 728 676 539 497 63 40 38 39 33
55–59 421 450 435 435 459 36 33 24 24 28
60–64 247 238 244 248 233 14 14 15 7 16
≥65 190 200 182 210 179 4 8 9 6 10
Region of residencea
Northeast 1,019 957 842 760 710 73 66 79 75 62
Midwest 1,238 1,195 1,219 1,095 983 132 134 104 127 142
South 2,927 2,883 2,764 2,704 2,616 279 259 272 249 274
West 1,889 1,713 1,683 1,604 1,493 237 228 210 205 206
Total 7,073 6,747 6,508 6,164 5,802 721 687 665 656 683
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 62 49 55 37 35 4 3 2 3 0
20–24 275 246 183 156 127 20 20 12 6 5
25–29 268 228 217 162 137 24 24 12 22 14
30–34 152 138 133 100 104 19 14 7 9 18
35–39 91 73 73 78 61 7 8 12 10 4
40–44 60 68 45 40 30 6 4 3 1 6
45–49 58 51 39 31 28 3 7 4 4 1
50–54 49 36 42 26 17 1 5 5 1 2
55–59 25 29 20 12 29 2 2 3 0 1
60–64 17 18 12 9 6 2 1 0 0 0
≥65 15 9 6 10 4 0 0 0 0 1
Region of residencea
Northeast 240 195 160 125 122 19 15 10 5 5
Midwest 139 128 129 100 71 10 15 10 11 9
South 460 414 376 300 286 29 36 27 21 26
West 233 209 159 135 99 29 20 13 20 11
Total 1,072 946 825 660 577 86 86 60 56 52
Total
Age at diagnosis (yr)
13–14 11 5 10 8 11 0 0 0 0 0
15–19 1,405 1,346 1,437 1,371 1,352 53 52 36 34 33
20–24 5,876 5,594 5,232 4,924 4,755 261 255 209 195 184
25–29 5,764 6,014 5,884 5,824 5,512 331 347 344 390 357
30–34 3,667 3,798 3,818 3,819 3,864 262 279 257 262 298
35–39 2,557 2,507 2,603 2,497 2,502 191 169 199 197 206
40–44 1,905 1,852 1,656 1,646 1,623 114 123 105 100 128
45–49 1,875 1,676 1,603 1,514 1,359 106 97 98 83 90
50–54 1,602 1,510 1,439 1,249 1,191 89 78 82 79 69
55–59 847 866 865 872 900 58 52 47 39 49
60–64 415 438 455 455 453 23 29 26 17 25
≥65 349 340 336 378 344 10 18 16 12 17
Region of residencea
Northeast 3,880 3,686 3,564 3,276 3,203 185 173 167 184 162
Midwest 3,519 3,496 3,473 3,270 3,054 215 245 192 222 235
South 13,047 12,965 12,681 12,490 12,325 637 621 607 545 630
West 5,827 5,800 5,619 5,519 5,284 462 459 455 456 430
   Total 26,273 25,947 25,337 24,556 23,866 1,499 1,498 1,421 1,408 1,457

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender persons.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 5b. Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
Male-to-male sexual contact Male-to-male sexual contact and injection drug use
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 4 2 2 7 7 1 0 0 0 1
20–24 30 24 18 25 26 0 4 3 2 3
25–29 21 37 32 22 29 1 5 6 7 6
30–34 16 30 18 20 18 0 3 6 5 1
35–39 12 11 15 10 19 3 2 1 2 2
40–44 6 14 12 9 6 0 0 2 1 0
45–49 5 6 6 7 6 0 0 1 3 1
50–54 5 5 8 6 9 0 1 0 1 1
55–59 4 3 2 3 5 0 0 0 0 0
60–64 0 3 2 2 2 0 0 1 0 0
≥65 0 1 1 3 0 0 1 1 0 0
Region of residencea
Northeast 3 7 2 5 5 0 0 0 0 0
Midwest 9 12 12 13 10 0 1 3 5 3
South 30 32 28 20 41 1 6 10 4 3
West 60 84 75 75 71 4 10 8 13 9
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 102 135 116 113 126 6 16 21 22 15
Asian
Age at diagnosis (yr)
13–14 1 0 0 1 0 0 0 0 0 0
15–19 21 19 23 22 19 0 1 0 0 0
20–24 118 109 148 106 91 3 3 2 1 3
25–29 170 155 152 166 133 4 2 4 4 3
30–34 106 123 112 121 94 3 3 5 2 5
35–39 72 79 91 71 77 3 1 1 2 1
40–44 81 86 72 61 44 4 1 1 1 0
45–49 62 51 67 57 52 2 1 3 1 1
50–54 34 31 34 23 34 1 1 0 0 0
55–59 15 18 19 19 18 0 0 0 0 0
60–64 4 8 9 11 7 0 0 0 0 0
≥65 5 11 7 10 9 0 1 0 0 0
Region of residencea
Northeast 110 136 128 130 106 3 3 3 1 3
Midwest 82 61 78 67 53 4 4 1 0 1
South 143 142 145 162 144 4 1 1 2 4
West 352 349 380 305 270 10 7 12 8 5
U.S. dependent areas 3 1 3 3 5 0 0 0 0 1
Total 690 690 734 668 579 20 14 15 12 14
Black/African American
Age at diagnosis (yr)
13–14 8 3 4 7 8 0 0 0 0 0
15–19 827 782 836 788 781 15 16 10 9 11
20–24 2,885 2,785 2,506 2,383 2,370 60 53 40 46 39
25–29 2,401 2,502 2,431 2,459 2,328 49 70 66 76 83
30–34 1,167 1,188 1,306 1,254 1,409 38 50 46 51 64
35–39 704 707 737 729 749 33 32 34 25 33
40–44 478 444 422 433 456 19 15 17 17 20
45–49 448 371 349 350 340 21 18 13 9 17
50–54 346 336 323 307 283 14 12 23 18 14
55–59 204 204 205 198 203 15 10 11 10 10
60–64 85 93 114 100 114 5 8 5 6 5
≥65 79 66 65 77 81 4 4 4 4 3
Region of residencea
Northeast 1,206 1,151 1,160 1,093 1,124 32 34 37 50 38
Midwest 1,546 1,598 1,521 1,470 1,427 41 61 45 51 46
South 6,059 5,886 5,792 5,676 5,766 164 153 135 127 164
West 814 844 822 842 805 38 41 51 43 51
U.S. dependent areas 5 3 1 4 1 0 0 0 0 0
Total 9,630 9,481 9,298 9,084 9,123 274 289 268 271 298
Hispanic/Latinob
Age at diagnosis (yr)
13–14 1 2 5 0 2 0 0 0 0 0
15–19 352 350 364 358 384 16 15 12 12 8
20–24 1,700 1,629 1,497 1,494 1,439 80 83 71 69 71
25–29 1,750 1,951 1,890 1,959 1,811 99 93 105 120 98
30–34 1,279 1,418 1,416 1,409 1,382 79 83 77 64 69
35–39 975 998 989 972 954 51 48 59 48 63
40–44 620 649 629 612 638 38 39 24 29 37
45–49 582 507 548 531 479 26 18 23 22 20
50–54 383 396 376 364 365 12 20 16 21 19
55–59 184 178 194 213 194 6 7 9 6 10
60–64 70 81 77 93 99 3 5 4 5 4
≥65 67 55 76 70 73 4 3 2 3 4
Region of residencea
Northeast 1,301 1,238 1,270 1,161 1,136 59 56 40 53 55
Midwest 504 502 512 523 505 29 29 28 29 35
South 3,414 3,602 3,570 3,619 3,460 159 167 163 143 159
West 2,445 2,584 2,474 2,520 2,513 144 150 160 162 145
U.S. dependent areas 301 287 234 251 207 23 10 11 12 8
Total 7,963 8,212 8,060 8,074 7,820 413 412 402 398 403
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 2 1 1 3 1 0 0 0 0 0
20–24 10 3 9 7 7 0 0 0 2 0
25–29 12 7 9 10 19 0 3 0 1 1
30–34 10 6 8 13 10 0 2 0 1 1
35–39 7 7 2 9 6 1 0 1 0 1
40–44 2 3 5 2 5 0 0 0 0 0
45–49 5 1 1 2 1 0 0 0 0 0
50–54 5 2 2 1 4 0 0 0 0 0
55–59 2 1 1 4 1 0 0 0 0 0
60–64 0 0 0 1 1 0 0 0 0 0
≥65 0 1 0 1 0 0 1 0 0 0
Region of residencea
Northeast 1 3 3 2 1 0 1 0 0 0
Midwest 1 1 2 2 6 0 0 0 0 0
South 15 5 6 10 13 1 0 0 0 0
West 35 18 25 37 32 0 4 1 4 2
U.S. dependent areas 2 4 2 1 2 0 1 0 0 1
Total 54 31 38 52 54 1 6 1 4 3
White
Age at diagnosis (yr)
13–14 1 0 1 0 1 0 0 0 0 0
15–19 142 151 165 169 130 16 18 12 10 14
20–24 919 863 920 799 737 102 92 82 69 66
25–29 1,213 1,188 1,196 1,101 1,097 156 154 157 164 157
30–34 976 942 868 940 887 126 127 119 132 143
35–39 734 669 724 649 661 96 81 94 110 104
40–44 691 610 489 518 458 53 66 60 51 64
45–49 742 709 609 558 466 54 54 56 45 50
50–54 799 728 677 540 497 63 40 38 39 33
55–59 421 450 435 436 459 36 33 24 24 28
60–64 247 238 244 248 233 14 14 15 7 16
≥65 190 200 182 210 180 4 8 9 6 10
Region of residencea
Northeast 1,019 957 842 760 710 73 66 79 75 62
Midwest 1,238 1,195 1,219 1,095 983 132 134 104 127 142
South 2,927 2,883 2,764 2,704 2,616 279 259 272 249 274
West 1,889 1,713 1,683 1,604 1,493 237 228 210 205 206
U.S. dependent areas 2 2 2 4 3 0 0 0 0 1
Total 7,074 6,749 6,510 6,168 5,805 721 687 665 656 684
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 62 49 55 37 35 4 3 2 3 0
20–24 275 246 183 156 127 20 20 12 6 5
25–29 268 228 217 162 137 24 24 12 22 14
30–34 152 138 133 100 104 19 14 7 9 18
35–39 91 73 74 78 61 7 8 12 10 4
40–44 60 68 45 40 30 6 4 3 1 6
45–49 58 51 39 31 28 3 7 4 4 1
50–54 49 36 42 26 17 1 5 5 1 2
55–59 25 29 20 12 29 2 2 3 0 1
60–64 17 18 12 9 6 2 1 0 0 0
≥65 15 9 6 10 4 0 0 0 0 1
Region of residencea
Northeast 240 195 160 125 122 19 15 10 5 5
Midwest 139 128 129 100 71 10 15 10 11 9
South 460 414 376 300 286 29 36 27 21 26
West 233 209 159 135 99 29 20 13 20 11
U.S. dependent areas 0 0 1 0 0 0 0 0 0 0
Total 1,072 946 826 660 577 86 86 60 56 52
Total
Age at diagnosis (yr)
13–14 11 5 10 8 11 0 0 0 0 0
15–19 1,409 1,354 1,445 1,384 1,358 53 53 36 34 33
20–24 5,937 5,658 5,282 4,970 4,797 265 255 210 196 187
25–29 5,834 6,069 5,926 5,880 5,554 334 350 348 393 361
30–34 3,705 3,845 3,859 3,856 3,904 264 281 259 265 300
35–39 2,596 2,543 2,631 2,518 2,527 194 172 201 198 208
40–44 1,937 1,873 1,675 1,673 1,638 120 124 105 100 128
45–49 1,903 1,696 1,619 1,536 1,371 107 98 100 83 90
50–54 1,620 1,534 1,462 1,266 1,207 91 78 82 79 69
55–59 855 883 876 885 909 58 52 47 41 50
60–64 424 441 458 463 462 23 29 26 18 25
≥65 356 343 338 380 347 12 18 16 13 18
Region of residencea
Northeast 3,880 3,686 3,564 3,276 3,203 185 173 167 184 162
Midwest 3,519 3,496 3,473 3,270 3,054 215 245 192 222 235
South 13,047 12,965 12,681 12,490 12,325 637 621 607 545 630
West 5,827 5,800 5,619 5,519 5,284 462 459 455 456 430
U.S. dependent areas 312 297 243 264 218 23 11 11 12 11
Total 26,585 26,244 25,580 24,819 24,084 1,522 1,510 1,432 1,420 1,469

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender persons.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 6a. Diagnoses of HIV infection attributed to injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States
Male Female
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 1 0 0 0 0 0 0
20–24 0 3 0 0 2 1 1 1 0 2
25–29 2 4 6 1 1 2 4 2 2 1
30–34 2 0 3 3 2 2 1 1 3 1
35–39 1 1 0 0 4 1 1 3 3 7
40–44 0 2 2 0 3 1 1 2 0 2
45–49 0 2 0 1 1 2 1 1 1 0
50–54 1 0 3 2 1 0 4 2 2 2
55–59 1 3 0 0 0 2 0 1 1 0
60–64 0 0 1 0 0 1 1 0 1 0
≥65 0 0 1 0 0 0 0 1 0 1
Region of residencea
Northeast 0 0 1 0 0 0 1 1 0 0
Midwest 0 0 2 3 4 1 1 1 2 4
South 2 3 2 1 3 4 1 4 7 6
West 5 13 11 6 8 9 11 9 5 7
Total 8 16 17 10 15 13 14 15 13 18
Asian
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0 0
20–24 0 1 0 1 0 0 1 0 0 0
25–29 1 1 0 1 2 1 1 2 0 1
30–34 7 2 1 2 0 2 1 0 2 2
35–39 1 3 3 0 3 1 1 0 1 1
40–44 4 1 3 2 1 0 0 1 1 1
45–49 2 2 3 1 2 1 1 0 0 1
50–54 2 1 2 1 2 0 0 1 0 0
55–59 0 1 0 0 1 0 0 0 0 0
60–64 1 0 0 1 1 1 1 0 0 0
≥65 1 1 0 0 0 0 0 1 0 0
Region of residencea
Northeast 8 3 4 5 3 1 1 1 1 1
Midwest 1 2 0 1 3 0 1 0 0 0
South 3 2 2 4 2 2 2 1 2 1
West 8 7 6 1 6 3 3 3 2 4
Total 19 13 12 10 14 5 7 6 5 6
Black/African American
Age at diagnosis (yr)
13–14 0 0 0 0 0 2 2 0 0 0
15–19 4 5 5 5 4 8 8 8 7 7
20–24 26 21 17 21 23 25 20 28 23 27
25–29 34 33 38 47 55 41 36 33 30 43
30–34 41 34 49 48 58 28 36 37 38 37
35–39 40 45 43 60 40 34 34 36 35 42
40–44 47 43 31 33 43 36 25 37 27 32
45–49 44 42 44 46 31 43 30 40 33 33
50–54 66 58 45 48 39 43 49 38 36 29
55–59 61 45 55 49 40 37 39 30 34 28
60–64 33 37 33 35 43 24 26 24 22 23
≥65 29 31 31 33 31 14 15 17 16 22
Region of residencea
Northeast 125 109 123 121 116 94 70 88 80 87
Midwest 48 51 61 59 56 51 48 56 48 45
South 209 187 176 199 196 153 163 149 139 151
West 42 45 32 46 40 36 40 36 34 41
Total 424 392 391 425 408 333 321 328 301 323
Hispanic/Latinob
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 1 2 5 3 1 4 4 6 2 6
20–24 26 20 20 25 17 28 14 21 21 17
25–29 35 36 41 37 43 18 35 22 22 21
30–34 45 51 61 66 48 20 28 36 30 23
35–39 52 45 45 54 48 21 17 25 29 33
40–44 41 28 44 39 45 18 17 21 16 17
45–49 36 33 41 39 24 22 18 18 20 18
50–54 37 42 40 40 30 17 17 16 17 15
55–59 26 25 23 28 22 11 16 8 13 9
60–64 10 11 12 13 14 4 7 7 12 7
≥65 15 14 13 8 11 5 7 3 6 4
Region of residencea
Northeast 107 99 118 106 89 46 52 47 55 45
Midwest 19 13 17 13 11 10 11 9 9 9
South 104 97 104 119 93 68 71 72 72 67
West 93 98 106 111 112 42 46 52 52 48
Total 323 307 344 349 304 166 180 181 188 170
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0 0
20–24 0 0 0 0 0 0 0 0 0 0
25–29 0 0 0 0 1 1 0 0 0 0
30–34 0 0 0 0 0 0 0 0 0 0
35–39 1 0 1 0 0 0 0 0 0 0
40–44 1 0 0 0 0 0 0 0 0 0
45–49 0 0 0 1 0 0 0 0 0 0
50–54 0 0 1 0 0 0 2 0 0 0
55–59 0 0 0 0 0 0 0 0 0 0
60–64 0 0 0 0 0 0 0 0 0 0
≥65 0 0 0 0 0 0 0 0 0 0
Region of residencea
Northeast 1 0 0 0 0 0 0 0 0 0
Midwest 0 0 0 0 1 0 0 0 0 0
South 0 0 0 0 0 0 0 0 0 0
West 1 0 2 1 0 1 2 0 0 0
Total 2 0 2 1 1 1 2 0 0 0
White
Age at diagnosis (yr)
13–14 0 0 0 0 0 1 0 0 0 0
15–19 1 4 4 3 0 9 5 9 8 7
20–24 40 28 36 37 41 51 42 51 51 42
25–29 80 76 86 98 104 88 94 88 80 86
30–34 77 61 91 106 112 85 68 92 97 104
35–39 52 63 73 110 100 55 59 77 93 94
40–44 49 42 47 61 67 59 44 53 68 72
45–49 65 50 57 48 65 47 42 36 49 54
50–54 55 51 38 51 42 40 38 40 42 36
55–59 32 27 37 32 43 26 18 30 27 36
60–64 20 17 19 20 15 11 15 8 9 14
≥65 11 16 18 8 9 6 9 6 6 4
Region of residencea
Northeast 74 81 98 115 95 72 87 91 91 80
Midwest 140 83 95 120 103 132 88 91 110 96
South 146 152 194 208 270 195 174 214 215 267
West 122 120 119 133 132 77 84 93 113 106
Total 481 436 506 574 599 476 432 490 530 549
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 1 0 1 0 1 1 2 3 2
20–24 3 3 2 4 4 3 3 5 6 2
25–29 5 9 5 6 4 3 6 7 11 10
30–34 8 0 3 4 9 9 3 3 4 3
35–39 1 7 3 4 2 3 8 5 4 6
40–44 2 6 3 4 2 1 4 2 5 6
45–49 2 2 5 2 3 4 7 3 4 3
50–54 7 6 3 7 4 5 5 3 5 5
55–59 4 4 3 3 3 8 6 3 1 3
60–64 2 2 2 1 0 1 0 0 3 1
≥65 3 0 1 0 2 1 1 0 2 1
Region of residencea
Northeast 9 8 9 6 12 8 9 12 11 8
Midwest 7 3 7 8 6 6 6 5 9 8
South 14 16 9 12 9 15 18 11 17 17
West 7 13 6 12 5 10 11 6 10 6
Total 37 39 30 37 33 38 44 33 46 40
Total
Age at diagnosis (yr)
13–14 0 0 0 0 0 3 2 0 0 0
15–19 6 12 14 13 6 23 18 26 20 21
20–24 96 75 75 87 87 108 81 106 101 91
25–29 157 159 177 189 211 152 176 154 146 161
30–34 180 148 209 230 230 145 137 169 174 170
35–39 148 165 168 228 199 114 119 147 164 181
40–44 144 121 129 139 162 115 92 116 116 130
45–49 149 130 149 139 126 118 100 98 109 110
50–54 168 158 132 149 119 104 115 100 102 88
55–59 125 105 119 113 110 83 80 70 76 76
60–64 65 67 66 71 73 42 49 40 48 46
≥65 59 63 64 50 54 26 32 28 29 32
Region of residencea
Northeast 323 300 352 352 315 221 219 240 238 221
Midwest 216 153 181 204 184 199 154 163 179 163
South 478 456 486 542 572 436 429 451 452 509
West 278 295 282 310 303 177 197 199 216 212
Total 1,295 1,203 1,301 1,407 1,375 1,033 1,000 1,053 1,084 1,106

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use are presented based on sex at birth and include transgender persons.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 6b. Diagnoses of HIV infection attributed to injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
Male Female
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 1 0 0 0 0 0 0
20–24 0 3 0 0 2 1 1 1 0 2
25–29 2 4 6 1 1 2 4 2 2 1
30–34 2 0 3 3 2 2 1 1 3 1
35–39 1 1 0 0 4 1 1 3 3 7
40–44 0 2 2 0 3 1 1 2 0 2
45–49 0 2 0 1 1 2 1 1 1 0
50–54 1 0 3 2 1 0 4 2 2 2
55–59 1 3 0 0 0 2 0 1 1 0
60–64 0 0 1 0 0 1 1 0 1 0
≥65 0 0 1 0 0 0 0 1 0 1
Region of residencea
Northeast 0 0 1 0 0 0 1 1 0 0
Midwest 0 0 2 3 4 1 1 1 2 4
South 2 3 2 1 3 4 1 4 7 6
West 5 13 11 6 8 9 11 9 5 7
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 8 16 17 10 15 13 14 15 13 18
Asian
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0 0
20–24 0 1 0 1 0 0 1 0 0 0
25–29 1 1 0 1 2 1 1 2 0 1
30–34 7 2 1 2 0 2 1 0 2 2
35–39 2 3 3 0 3 1 1 0 1 1
40–44 4 1 3 3 1 0 0 1 1 1
45–49 2 2 3 1 2 1 1 0 0 1
50–54 2 1 2 1 2 0 0 1 0 0
55–59 0 1 0 0 1 0 0 0 0 0
60–64 1 0 0 1 1 1 1 0 0 0
≥65 1 1 0 0 0 0 0 1 0 0
Region of residencea
Northeast 8 3 4 5 3 1 1 1 1 1
Midwest 1 2 0 1 3 0 1 0 0 0
South 3 2 2 4 2 2 2 1 2 1
West 8 7 6 1 6 3 3 3 2 4
U.S. dependent areas 1 0 0 1 0 0 0 0 0 0
Total 20 13 12 11 14 5 7 6 5 6
Black/African American
Age at diagnosis (yr)
13–14 0 0 0 0 0 2 2 0 0 0
15–19 4 5 5 5 4 8 8 8 7 7
20–24 26 21 17 21 23 25 20 28 23 27
25–29 34 33 38 47 55 41 36 33 30 43
30–34 41 34 50 48 58 28 36 37 38 37
35–39 40 45 43 60 40 34 34 36 35 42
40–44 47 43 31 34 43 36 25 37 27 32
45–49 44 42 44 46 31 43 30 40 33 33
50–54 66 58 45 48 39 43 49 38 36 29
55–59 61 45 55 50 41 37 39 30 34 28
60–64 33 38 33 35 43 24 26 24 22 23
≥65 29 31 31 33 31 14 15 17 16 22
Region of residencea
Northeast 125 109 123 121 116 94 70 88 80 87
Midwest 48 51 61 59 56 51 48 56 48 45
South 209 187 176 199 196 153 163 149 139 151
West 42 45 32 46 40 36 40 36 34 41
U.S. dependent areas 0 1 0 1 1 0 0 0 0 0
Total 425 393 391 426 409 334 321 328 301 323
Hispanic/Latinob
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 2 2 5 3 1 4 4 6 2 6
20–24 27 23 20 25 18 30 15 21 21 17
25–29 39 37 43 39 44 19 36 22 22 21
30–34 52 53 65 68 49 21 29 36 31 23
35–39 58 51 45 55 52 23 19 27 29 34
40–44 47 33 45 43 49 19 19 21 16 17
45–49 42 37 44 42 26 22 19 21 21 20
50–54 47 44 49 45 32 18 19 17 17 16
55–59 32 32 27 29 24 11 16 9 13 10
60–64 13 15 16 15 16 4 9 8 12 7
≥65 17 17 17 11 15 5 7 3 6 4
Region of residencea
Northeast 107 99 118 106 89 46 52 47 55 45
Midwest 19 13 17 13 11 10 11 9 9 9
South 104 97 104 119 93 68 71 72 72 67
West 93 98 106 111 112 42 46 52 52 48
U.S. dependent areas 51 36 32 23 22 7 12 9 2 5
Total 374 343 376 372 326 173 191 190 189 175
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 0 0
20–24 0 0 0 0 0 0 0 0 0 0
25–29 0 0 0 0 1 1 0 0 0 0
30–34 0 0 0 0 0 0 0 0 0 0
35–39 1 0 1 0 0 0 0 0 0 0
40–44 1 0 0 0 0 0 0 0 0 0
45–49 0 0 0 1 0 0 0 0 0 0
50–54 0 0 1 0 0 0 2 0 0 0
55–59 0 0 0 0 0 0 0 0 0 0
60–64 0 0 0 0 0 0 0 0 0 0
≥65 0 0 0 0 0 0 0 0 0 0
Region of residencea
Northeast 1 0 0 0 0 0 0 0 0 0
Midwest 0 0 0 0 1 0 0 0 0 0
South 0 0 0 0 0 0 0 0 0 0
West 1 0 2 1 0 1 2 0 0 0
U.S. dependent areas 0 1 0 0 0 0 0 0 0 0
Total 3 1 2 2 1 1 2 0 0 0
White
Age at diagnosis (yr)
13–14 0 0 0 0 0 1 0 0 0 0
15–19 1 4 4 3 0 9 5 10 8 7
20–24 40 28 36 37 41 51 42 51 51 42
25–29 80 76 86 98 104 88 94 88 80 86
30–34 77 61 91 106 112 85 68 92 97 104
35–39 52 63 73 110 100 55 59 77 93 94
40–44 49 42 47 61 67 59 44 53 68 72
45–49 65 50 57 48 65 47 42 36 49 54
50–54 55 51 38 51 42 40 38 40 42 36
55–59 32 27 37 32 43 26 18 30 27 36
60–64 20 17 19 20 15 11 15 8 9 14
≥65 11 16 18 8 9 6 9 6 6 4
Region of residencea
Northeast 74 81 98 115 95 72 87 91 91 80
Midwest 140 83 95 120 103 132 88 91 110 96
South 146 152 194 208 270 195 174 214 215 267
West 122 120 119 133 132 77 84 93 113 106
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 481 436 506 574 599 476 432 490 530 549
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 1 0 1 0 1 1 2 3 2
20–24 3 3 2 4 4 3 3 5 6 2
25–29 5 9 5 6 4 3 6 7 11 10
30–34 8 0 3 4 9 9 3 3 4 3
35–39 1 7 3 4 2 3 8 5 4 6
40–44 2 6 3 4 2 1 4 2 5 6
45–49 2 2 5 2 3 4 7 3 4 3
50–54 7 6 3 7 4 5 5 3 5 5
55–59 4 4 3 3 3 8 6 3 1 3
60–64 2 2 2 2 0 1 0 0 3 1
≥65 3 0 1 0 2 1 1 0 2 1
Region of residencea
Northeast 9 8 9 6 12 8 9 12 11 8
Midwest 7 3 7 8 6 6 6 5 9 8
South 14 16 9 12 9 15 18 11 17 17
West 7 13 6 12 5 10 11 6 10 6
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 37 39 30 37 33 38 44 33 46 40
Total
Age at diagnosis (yr)
13–14 0 0 0 0 0 3 2 0 0 0
15–19 7 12 14 14 6 23 18 26 20 21
20–24 97 78 75 87 87 109 82 106 101 91
25–29 161 160 179 191 212 153 177 154 146 161
30–34 187 150 213 232 230 146 138 169 175 170
35–39 155 171 168 229 203 116 121 149 164 182
40–44 150 126 131 144 166 116 94 116 116 130
45–49 155 135 152 142 128 118 101 101 109 112
50–54 178 160 141 155 121 105 117 101 102 89
55–59 131 112 123 114 113 83 80 71 76 77
60–64 67 72 70 73 75 42 51 41 48 46
≥65 61 65 68 52 57 27 32 28 29 32
Region of residencea
Northeast 323 300 352 352 315 221 219 240 238 221
Midwest 216 153 181 204 184 199 154 163 179 163
South 478 456 486 542 572 436 429 451 452 509
West 278 295 282 310 303 177 197 199 216 212
U.S. dependent areas 53 38 32 25 23 7 12 9 2 5
Total 1,348 1,241 1,333 1,432 1,397 1,040 1,011 1,062 1,086 1,111

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use are presented based on sex at birth and include transgender persons.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 7a. Diagnoses of HIV infection attributed to heterosexual contact, by year of diagnosis, race/ethnicity and selected characteristics, 2015–2019—United States
Male Female
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 1 0 1 0 0 1 1
20–24 1 0 0 1 2 2 0 2 1 2
25–29 0 0 1 1 0 6 4 5 2 2
30–34 1 1 2 1 1 6 3 2 1 4
35–39 1 1 3 1 0 5 7 5 2 6
40–44 0 1 0 0 2 5 6 3 3 6
45–49 3 1 0 0 0 3 3 6 3 3
50–54 2 1 0 1 1 2 1 5 2 2
55–59 1 0 1 1 1 2 2 1 2 1
60–64 0 0 0 0 0 0 1 2 0 1
≥65 0 1 0 0 0 1 1 0 0 1
Region of residencea
Northeast 2 0 0 1 0 1 3 0 0 0
Midwest 1 1 0 1 2 6 1 4 1 10
South 2 2 4 2 5 13 9 5 7 5
West 4 5 4 3 1 11 14 22 7 12
Total 9 8 8 8 8 32 27 30 16 27
Asian
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 1 0 0 0
15–19 0 0 0 0 1 2 0 1 0 2
20–24 0 3 2 5 0 14 9 7 7 7
25–29 6 1 2 1 3 16 19 19 17 8
30–34 4 9 4 8 2 18 29 8 16 16
35–39 16 14 10 9 2 18 25 25 10 15
40–44 9 4 4 11 5 16 15 10 12 6
45–49 8 8 6 6 4 9 11 12 7 14
50–54 7 5 2 5 6 7 10 11 8 4
55–59 5 4 2 3 3 3 8 7 9 8
60–64 1 4 4 5 3 7 4 7 4 7
≥65 4 5 3 5 3 4 5 4 6 5
Region of residencea
Northeast 9 8 9 14 11 20 32 18 28 12
Midwest 7 11 6 3 1 17 12 18 6 12
South 24 23 11 23 11 38 41 29 24 30
West 20 17 14 19 7 39 49 44 37 37
Total 60 59 39 59 31 114 134 109 94 90
Black/African American
Age at diagnosis (yr)
13–14 1 0 0 0 0 7 6 5 3 5
15–19 29 40 23 31 28 148 140 139 134 95
20–24 166 154 128 114 121 437 390 407 393 389
25–29 237 251 199 225 174 508 548 505 476 454
30–34 207 230 195 236 190 517 515 521 455 464
35–39 222 234 221 210 182 526 534 482 447 417
40–44 253 229 186 165 170 418 414 401 417 369
45–49 249 221 185 168 193 387 424 389 355 325
50–54 261 227 201 201 179 376 375 336 328 323
55–59 213 182 184 165 159 281 304 294 293 278
60–64 128 122 129 105 128 171 188 196 167 196
≥65 108 119 114 108 123 134 124 169 130 159
Region of residencea
Northeast 385 347 324 267 247 699 669 656 562 534
Midwest 196 195 188 204 190 490 503 515 484 491
South 1,396 1,376 1,190 1,182 1,142 2,468 2,498 2,432 2,269 2,185
West 96 91 63 75 65 254 292 240 283 261
Total 2,073 2,009 1,765 1,728 1,644 3,911 3,962 3,844 3,599 3,471
Hispanic/Latinob
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 1 2 3 4
15–19 7 5 8 7 7 47 34 40 35 37
20–24 32 55 30 31 27 142 115 125 107 117
25–29 54 79 72 67 79 147 155 163 157 154
30–34 89 92 82 88 74 154 182 155 155 152
35–39 110 91 85 89 72 155 141 139 171 127
40–44 84 84 85 75 75 138 133 115 118 126
45–49 70 86 61 80 59 112 110 133 125 101
50–54 65 57 58 70 55 122 107 98 115 97
55–59 46 39 42 48 37 63 76 74 83 64
60–64 26 32 32 21 36 35 43 44 52 51
≥65 34 25 29 32 24 30 41 38 45 44
Region of residencea
Northeast 151 162 139 141 108 278 304 259 238 219
Midwest 39 41 30 36 33 53 58 62 58 69
South 346 337 320 346 317 590 547 581 628 551
West 81 106 95 84 86 225 228 223 241 235
Total 616 645 583 606 544 1,146 1,137 1,126 1,165 1,074
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 1 1
20–24 0 0 0 0 0 2 1 0 0 1
25–29 0 0 1 0 1 0 0 2 0 2
30–34 0 0 1 2 0 1 1 3 2 1
35–39 2 1 0 0 0 0 1 2 0 2
40–44 0 0 0 0 0 0 0 0 0 1
45–49 1 1 1 0 0 0 0 0 0 0
50–54 1 0 0 0 0 1 1 0 1 1
55–59 0 0 0 0 0 1 0 1 1 0
60–64 0 0 0 0 0 0 0 0 0 0
≥65 0 0 1 0 0 0 0 0 0 0
Region of residencea
Northeast 0 0 1 1 0 0 0 1 1 0
Midwest 0 1 0 0 0 2 0 0 0 4
South 0 1 1 1 0 1 0 2 1 1
West 5 0 2 0 1 2 4 5 3 4
Total 5 3 4 2 2 5 4 8 5 9
White
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 1 2 0
15–19 2 4 5 2 4 18 31 28 32 33
20–24 14 32 16 20 18 88 104 97 89 95
25–29 37 35 47 50 49 115 132 108 123 129
30–34 33 46 49 60 44 114 138 128 123 133
35–39 31 47 45 51 42 99 109 110 112 126
40–44 50 51 50 44 45 100 90 81 104 94
45–49 64 46 51 49 53 105 103 108 101 105
50–54 45 75 62 44 51 102 101 97 96 95
55–59 44 52 48 51 49 86 89 101 70 78
60–64 37 35 35 41 24 32 55 40 39 46
≥65 49 42 35 29 28 24 23 23 26 21
Region of residencea
Northeast 76 98 84 83 65 121 126 116 111 113
Midwest 48 50 52 57 63 156 160 154 166 179
South 221 250 232 237 213 466 498 493 478 482
West 60 67 74 65 66 139 191 159 163 181
Total 406 465 442 441 407 882 975 922 917 954
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 1 0 0
15–19 3 0 1 1 0 10 7 5 12 9
20–24 8 8 4 3 2 21 31 27 15 15
25–29 9 12 8 8 8 26 22 20 25 30
30–34 8 5 12 13 4 30 28 25 26 23
35–39 6 19 8 5 3 29 27 21 20 20
40–44 7 11 11 4 5 16 16 12 11 17
45–49 9 8 8 7 6 27 24 18 20 17
50–54 11 9 4 9 4 24 14 13 9 15
55–59 9 8 5 1 6 14 15 10 9 5
60–64 3 4 6 3 2 7 5 3 10 6
≥65 8 3 4 4 7 3 9 5 8 6
Region of residencea
Northeast 24 26 19 19 13 54 41 40 35 37
Midwest 8 12 9 6 13 21 39 22 21 30
South 40 43 38 31 20 111 99 72 82 76
West 8 6 6 2 3 21 20 25 25 19
Total 81 87 71 59 49 208 199 159 163 162
Total
Age at diagnosis (yr)
13–14 1 0 0 0 0 7 8 8 7 9
15–19 40 49 37 43 40 226 212 213 216 178
20–24 221 253 180 174 171 706 651 664 611 625
25–29 343 378 331 353 314 819 879 822 799 779
30–34 342 384 345 408 315 841 896 842 777 793
35–39 388 407 372 364 300 833 844 783 762 711
40–44 402 380 335 299 301 692 673 623 665 618
45–49 404 372 313 311 315 642 674 666 610 565
50–54 392 375 326 329 296 634 609 559 557 536
55–59 318 284 282 269 256 450 493 489 467 433
60–64 195 198 205 175 193 252 296 292 272 306
≥65 202 196 186 179 185 196 203 239 215 235
Region of residencea
Northeast 647 642 575 526 444 1,173 1,176 1,091 974 915
Midwest 299 311 285 306 302 745 773 776 735 793
South 2,030 2,031 1,796 1,824 1,709 3,688 3,691 3,614 3,490 3,330
West 273 292 257 247 229 692 797 718 759 749
Total 3,249 3,275 2,913 2,903 2,685 6,298 6,437 6,198 5,958 5,787

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
Persons whose transmission category is classified as heterosexual contact are presented based on sex at birth and includes transgender persons.
Persons whose transmission category is classified as heterosexual contact are persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). The heterosexual contact category excludes men who have ever had sexual contact with both men and women.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 7b. Diagnoses of HIV infection attributed to heterosexual contact, by year of diagnosis, race/ethnicity and selected characteristics, 2015–2019—United States and 6 dependent areas
Male Female
2015 2016 2017 2018 2019 2015 2016 2017 2018 2019
No. No. No. No. No. No. No. No. No. No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 1 0 1 0 0 1 1
20–24 1 0 0 1 2 2 0 2 1 2
25–29 0 0 1 1 0 6 4 5 2 2
30–34 1 1 2 1 1 6 3 2 1 4
35–39 1 1 3 1 0 5 7 5 2 6
40–44 0 1 0 0 2 5 6 3 3 6
45–49 3 1 0 0 0 3 3 6 3 3
50–54 2 1 0 1 1 2 1 5 2 2
55–59 1 0 1 1 1 2 2 1 2 1
60–64 0 0 0 0 0 0 1 2 0 1
≥65 0 1 0 0 0 1 1 0 0 1
Region of residencea
Northeast 2 0 0 1 0 1 3 0 0 0
Midwest 1 1 0 1 2 6 1 4 1 10
South 2 2 4 2 5 13 9 5 7 5
West 4 5 4 3 1 11 14 22 7 12
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 9 8 8 8 8 32 27 30 16 27
Asian
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 1 0 0 0
15–19 0 0 0 0 1 2 0 1 0 2
20–24 0 3 2 5 0 14 9 7 7 7
25–29 6 1 2 1 3 16 19 19 17 8
30–34 4 9 4 8 2 18 29 8 16 16
35–39 16 14 10 9 2 18 25 25 10 15
40–44 9 4 4 11 5 16 15 10 12 6
45–49 8 8 6 6 4 9 11 12 7 14
50–54 7 5 2 5 6 7 10 11 8 4
55–59 5 4 2 3 3 3 8 7 9 8
60–64 1 4 4 5 3 7 4 7 4 7
≥65 4 5 3 5 3 4 5 4 6 5
Region of residencea
Northeast 9 8 9 14 11 20 32 18 28 12
Midwest 7 11 6 3 1 17 12 18 6 12
South 24 23 11 23 11 38 41 29 24 30
West 20 17 14 19 7 39 49 44 37 37
U.S. dependent areas 0 0 0 0 0 0 0 0 0 0
Total 60 59 39 59 31 114 134 109 94 90
Black/African American
Age at diagnosis (yr)
13–14 1 0 0 0 0 7 6 5 3 5
15–19 29 40 23 31 28 148 140 139 134 95
20–24 166 154 128 114 121 437 390 407 393 389
25–29 237 251 199 226 174 510 548 505 476 454
30–34 207 230 195 236 190 517 515 522 455 464
35–39 222 234 221 210 182 526 534 482 447 417
40–44 253 229 186 166 170 418 414 401 417 369
45–49 249 222 185 168 193 387 424 390 355 326
50–54 261 227 201 201 179 376 375 336 328 323
55–59 213 182 184 165 159 281 304 294 293 278
60–64 128 123 129 105 128 171 188 196 167 196
≥65 108 119 114 108 124 136 124 169 130 159
Region of residencea
Northeast 385 347 324 267 247 699 669 656 562 534
Midwest 196 195 188 204 190 490 503 515 484 491
South 1,396 1,376 1,190 1,182 1,142 2,468 2,498 2,432 2,269 2,185
West 96 91 63 75 65 254 292 240 283 261
U.S. dependent areas 0 2 0 2 2 4 0 2 0 2
Total 2,073 2,011 1,765 1,731 1,646 3,915 3,962 3,846 3,599 3,473
Hispanic/Latinob
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 1 2 3 4
15–19 7 5 9 7 7 49 36 43 37 37
20–24 38 56 38 34 31 150 120 130 115 121
25–29 61 83 77 75 83 156 160 175 164 160
30–34 96 98 91 97 80 160 190 160 161 161
35–39 120 100 96 94 76 164 157 149 175 131
40–44 90 98 95 77 81 153 147 122 126 140
45–49 87 104 67 84 71 127 124 144 139 108
50–54 78 68 65 84 59 135 114 108 127 101
55–59 53 49 49 52 48 75 90 84 91 76
60–64 29 42 41 25 43 36 49 48 57 56
≥65 43 42 39 41 33 40 43 42 51 52
Region of residencea
Northeast 151 162 139 141 108 278 304 259 238 219
Midwest 39 41 30 36 33 53 58 62 58 69
South 346 337 320 346 317 590 547 581 628 551
West 81 106 95 84 86 225 228 223 241 235
U.S. dependent areas 86 100 83 63 67 100 93 81 80 73
Total 702 745 666 669 611 1,246 1,230 1,207 1,245 1,147
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 0 0 0
15–19 0 0 0 0 0 0 0 0 1 1
20–24 0 0 1 0 0 2 1 0 0 2
25–29 0 0 1 0 1 0 0 2 0 2
30–34 0 0 1 2 0 1 1 3 2 1
35–39 2 1 0 0 0 0 1 2 0 2
40–44 0 0 0 0 0 0 0 0 0 1
45–49 1 1 1 0 0 0 0 0 0 0
50–54 2 0 0 0 0 1 1 0 1 1
55–59 0 0 0 0 0 1 0 1 1 0
60–64 0 0 0 0 0 0 0 0 0 0
≥65 0 0 1 0 0 0 0 0 0 0
Region of residencea
Northeast 0 0 1 1 0 0 0 1 1 0
Midwest 0 1 0 0 0 2 0 0 0 4
South 0 1 1 1 0 1 0 2 1 1
West 5 0 2 0 1 2 4 5 3 4
U.S. dependent areas 0 0 1 0 0 0 0 0 0 1
Total 5 3 5 3 2 5 4 8 5 10
White
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 1 2 0
15–19 2 4 5 2 4 18 31 28 32 33
20–24 14 32 16 20 18 88 104 97 89 95
25–29 37 35 47 50 49 115 132 108 123 129
30–34 33 46 49 60 44 114 138 128 123 133
35–39 31 47 45 51 42 99 109 110 112 126
40–44 50 51 50 44 45 100 90 81 104 94
45–49 64 46 51 49 54 105 103 108 101 105
50–54 45 75 62 44 51 102 101 98 96 95
55–59 44 52 48 51 49 86 89 101 70 78
60–64 37 35 35 41 24 32 55 40 39 46
≥65 49 42 35 29 28 24 23 23 26 21
Region of residencea
Northeast 76 98 84 83 65 121 126 116 111 113
Midwest 48 50 52 57 63 156 160 154 166 179
South 221 250 232 237 213 466 498 493 478 482
West 60 67 74 65 66 139 191 159 163 181
U.S. dependent areas 0 0 0 0 1 0 0 2 0 0
Total 406 465 442 441 408 882 975 924 917 954
Multiracial
Age at diagnosis (yr)
13–14 0 0 0 0 0 0 0 1 0 0
15–19 3 0 1 1 0 10 7 5 12 9
20–24 8 8 4 3 2 22 31 27 15 15
25–29 9 12 8 8 8 26 22 20 25 30
30–34 8 5 12 13 4 30 28 25 26 23
35–39 6 19 8 6 3 29 27 21 20 20
40–44 7 11 11 4 5 16 16 12 11 17
45–49 9 8 8 7 6 27 24 18 20 17
50–54 11 9 4 9 4 24 14 13 9 15
55–59 9 8 5 1 6 14 15 10 9 5
60–64 3 4 6 4 2 7 5 3 10 6
≥65 8 3 4 4 7 3 9 5 8 6
Region of residencea
Northeast 24 26 19 19 13 54 41 40 35 37
Midwest 8 12 9 6 13 21 39 22 21 30
South 40 43 38 31 20 111 99 72 82 76
West 8 6 6 2 3 21 20 25 25 19
U.S. dependent areas 0 0 0 2 0 1 0 0 0 0
Total 81 87 71 60 49 209 199 159 163 162
Total
Age at diagnosis (yr)
13–14 1 0 0 0 0 7 8 8 7 9
15–19 40 49 38 43 40 228 214 216 218 178
20–24 226 254 189 177 174 715 656 669 619 630
25–29 351 382 335 362 317 830 884 834 806 785
30–34 349 390 354 417 322 847 904 848 783 802
35–39 398 416 384 370 304 842 860 793 766 715
40–44 409 394 346 302 308 707 687 630 673 632
45–49 421 390 318 315 328 657 688 678 624 573
50–54 406 386 333 343 300 647 616 570 569 541
55–59 325 294 289 273 267 462 507 499 475 445
60–64 198 209 214 180 200 253 301 295 277 311
≥65 212 213 197 188 195 208 205 243 221 243
Region of residencea
Northeast 647 642 575 526 444 1,173 1,176 1,091 974 915
Midwest 299 311 285 306 302 745 773 776 735 793
South 2,030 2,031 1,796 1,824 1,709 3,688 3,691 3,614 3,490 3,330
West 273 292 257 247 229 692 797 718 759 749
U.S. dependent areas 86 102 85 67 70 105 93 85 80 76
Total 3,335 3,377 2,997 2,970 2,754 6,402 6,530 6,283 6,037 5,863

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
Persons whose transmission category is classified as heterosexual contact are presented based on sex at birth and includes transgender persons.
Persons whose transmission category is classified as heterosexual contact are persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). The heterosexual contact category excludes men who have ever had sexual contact with both men and women.

aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.

Table 8a. Diagnoses of HIV infection among adolescents and young adults, by 2-year and 3-year age groups, and selected characteristics, 2019—United States
13–14 years of age at diagnosis 15–17 years of age at diagnosis 18–19 years of age at diagnosis 20–22 years of age at diagnosis 23–24 years of age at diagnosis Total
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 12 301 1,099 2,833 2,202 6,447
Female 9 71 131 392 323 926
Transgender male-to-femaleb 0 10 25 110 48 193
Transgender female-to-maleb 0 0 0 9 2 11
Additional gender identityc 0 0 3 5 3 11
Race/Ethnicity 
American Indian/Alaska Native 0 0.0 1 1.0 8 11.0 20 18.4 17 23.2 46 10.7
Asian 0 0.0 6 0.9 16 3.5 55 7.7 47 8.7 124 4.4
Black/African American 14 1.2 224 13.3 707 58.6 1,775 98.0 1,203 96.3 3,923 55.3
Hispanic/Latinod 6 0.3 102 3.4 339 16.8 894 30.7 753 38.9 2,094 17.5
Native Hawaiian/Other Pacific Islander 0 0.0 0 0.0 2 12.0 4 15.9 4 22.3 10 9.9
White 1 0.0 40 0.6 149 3.3 517 7.5 483 10.3 1,190 4.4
Multiracial 0 0.0 9 2.0 37 12.6 84 20.3 71 27.4 201 11.4
Transmission Categorye
Males
Male-to-male sexual contact 11 286 1,066 2,746 2,009 6,118
Injection drug use 0 1 4 34 53 92
Male-to-male sexual contact and injection drug use 0 8 25 85 99 217
Heterosexual contactf 0 11 28 80 91 210
Perinatalg 1 5 1 2 2 12
Otherh 0 0 0 0 0 1
Subtotal 12 0.3 311 4.9 1,126 25.7 2,948 44.9 2,253 50.1 6,650 25.5
Females
Injection drug use 0 10 12 43 48 112
Heterosexual contactf 9 59 119 352 273 812
Perinatalg 0 3 1 6 4 14
Otherh 0 0 0 0 0 0
Subtotal 9 0.2 71 1.2 132 3.1 401 6.4 325 7.6 938 3.8
Region of Residencei     
Northeast 5 0.4 49 2.4 159 10.8 446 20.6 312 21.5 971 11.5
Midwest 4 0.2 56 2.1 177 9.8 475 17.2 375 20.5 1,087 10.1
South 9 0.3 229 4.8 750 22.8 1,840 37.7 1,408 42.3 4,236 21.6
West 3 0.1 48 1.6 172 8.6 588 19.4 483 22.1 1,294 10.6
Total 21 0.3 382 3.1 1,258 14.7 3,349 26.1 2,578 29.3 7,588 14.9

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dHispanic/Latino persons can be of any race.
eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
iData are based on residence at time of diagnosis of HIV infection.

Table 8b. Diagnoses of HIV infection among adolescents and young adults, by 2-year and 3-year age groups, and selected characteristics, 2019—United States and 6 dependent areas
  13–14 years of age at diagnosis 15–17 years of age at diagnosis 18–19 years of age at diagnosis 20–22 years of age at diagnosis 23–24 years of age at diagnosis Total
  No. No. No. No. No. No.
Gender
Male 12 301 1,105 2,858 2,225 6,501
Female 9 71 131 395 325 931
Transgender male-to-femalea 0 10 25 111 48 194
Transgender female-to-malea 0 0 0 9 2 11
Additional gender identityb 0 0 3 5 3 11
Race/Ethnicity
American Indian/Alaska Native 0 1 8 20 17 46
Asian 0 6 16 55 47 124
Black/African American 14 224 707 1,776 1,203 3,924
Hispanic/Latinoc 6 102 345 921 778 2,152
Native Hawaiian/Other Pacific Islander 0 0 2 5 4 11
White 1 40 149 517 483 1,190
Multiracial 0 9 37 84 71 201
Transmission Categoryd
Males
Male-to-male sexual contact 11 286 1,072 2,767 2,030 6,165
Injection drug use 0 1 4 34 53 93
Male-to-male sexual contact and injection drug use 0 8 25 87 100 220
Heterosexual contacte 0 11 28 83 91 214
Perinatalf 1 5 1 2 2 12
Otherg 0 0 0 0 0 1
Subtotal 12 311 1,132 2,974 2,276 6,705
Females
Injection drug use 0 10 12 43 48 112
Heterosexual contacte 9 59 119 355 275 817
Perinatalf 0 3 1 6 4 14
Otherg 0 0 0 0 0 0
Subtotal 9 71 132 404 327 943
Region of Residenceh
Northeast 5 49 159 446 312 971
Midwest 4 56 177 475 375 1,087
South 9 229 750 1,840 1,408 4,236
West 3 48 172 588 483 1,294
U.S. dependent areas 0 0 6 29 25 60
Total 21 382 1,264 3,378 2,603 7,648

Note: Numbers less than 12 should be interpreted with caution.

aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
cHispanic/Latino persons can be of any race.
dData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
eHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
fIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
gIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
hData are based on residence at time of diagnosis of HIV infection.

Table 9a. Diagnoses of HIV infection among children aged less than 13 years, by year of diagnosis and race/ethnicity, 2015–2019—United States
2015 2016 2017 2018 2019
Race/ethnicity No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
American Indian/Alaska Native 2 0.4 0 0.0 0 0.0 0 0.0 1 0.2
Asian 11 0.4 8 0.3 6 0.2 5 0.2 5 0.2
Black/African American 87 1.2 78 1.1 57 0.8 52 0.7 35 0.5
Hispanic/Latinob 13 0.1 18 0.1 16 0.1 10 0.1 8 0.1
Native Hawaiian/other Pacific Islander 0 0.0 0 0.0 1 0.9 0 0.0 0 0.0
White 17 0.1 17 0.1 16 0.1 16 0.1 7 0.0
Multiracial 12 0.5 7 0.3 8 0.3 6 0.2 5 0.2
Total 142 0.3 128 0.2 104 0.2 89 0.2 61 0.1

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population.
bHispanic/Latino persons can be of any race.

Table 9b. Diagnoses of HIV infection among children aged less than 13 years, by year of diagnosis and race/ethnicity, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
Race/ethnicity No. No. No. No. No.
American Indian/Alaska Native 2 0 0 0 1
Asian 11 8 6 5 5
Black/African American 87 78 57 52 35
Hispanic/Latinoa 13 18 16 10 8
Native Hawaiian/other Pacific Islander 0 0 1 0 0
White 17 17 16 16 7
Multiracial 12 7 8 6 5
Total 142 128 104 89 61

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aHispanic/Latino persons can be of any race.

Table 10. Diagnoses of HIV infection among adult and adolescent Hispanic/Latino persons, by transmission category and place of birth, 2019—United States and 6 dependent areas
Central America Cuba Mexico Puerto Rico South America United States Total
Transmission categorya No. % No. % No. % No. % No. % No. % No.b %
Male adult or adolescentc
Male-to-male sexual contact 431 82.2 275 89.4 804 88.3 302 68.5 654 91.6 2,598 84.7 7,820 85.3
Injection drug use 14 2.7 1 0.3 20 2.2 41 9.3 4 0.5 120 3.9 326 3.6
Male-to-male sexual contact
and injection drug use
10 2.0 3 0.9 20 2.2 13 2.9 9 1.3 197 6.4 403 4.4
Heterosexual contactd 69 13.1 29 9.4 65 7.2 84 19.1 46 6.4 147 4.8 611 6.7
Perinatale 0 0.0 0 0.0 0 0.0 0 0.0 1 0.2 2 0.1 3 0.0
Otherf 0 0.1 0 0.0 1 0.1 0 0.1 0 0.1 2 0.1 6 0.1
Subtotal 524 100 308 100 910 100 441 100 714 100 3,066 100 9,168 100
Female adult or adolescentc
Injection drug use 5 4.0 3 5.8 4 4.6 9 8.3 3 4.8 82 19.7 175 13.2
Heterosexual contactd 123 95.0 41 94.2 87 95.2 94 91.7 66 95.1 334 80.2 1,147 86.5
Perinatale 1 0.9 0 0.0 0 0.2 0 0.1 0 0.1 0 0.1 4 0.3
Otherf 0 0.2 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Subtotal 129 100 43 100 91 100 103 100 69 100 416 100 1,326 100
Total 653 100 351 100 1,001 100 544 100 783 100 3,482 100 10,494 100

Note: Numbers less than 12, and percentages based on these numbers, should be interpreted with caution. Hispanic/Latino persons can be of any race.

aData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
bTotal includes persons whose place of birth is not among those listed and persons whose place of birth is unknown.
cData presented based on sex at birth and includes transgender persons.
dHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
eIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
fIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.

Table 11a. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 11,850 12,241 12,257 12,068 11,701
Female 3,891 4,025 3,992 3,986 3,624
Transgender male-to-femaleb 108 121 104 119 134
Transgender female-to-maleb 5 2 4 3 5
Additional gender identityc 1 0 1 1 1
Age at death (yr)
<13 4 0.0 2 0.0 2 0.0 1 0.0 2 0.0
13–14 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0
15–19 11 0.1 10 0.0 7 0.0 9 0.0 11 0.1
20–24 150 0.7 156 0.7 143 0.6 121 0.6 116 0.5
25–29 399 1.8 447 2.0 446 1.9 418 1.8 403 1.7
30–34 591 2.7 659 3.0 601 2.7 609 2.8 636 2.8
35–39 817 4.0 835 4.0 867 4.1 814 3.8 801 3.7
40–44 1,224 6.1 1,131 5.7 968 4.9 950 4.8 880 4.4
45–49 1,998 9.6 1,809 8.7 1,737 8.3 1,599 7.7 1,334 6.5
50–54 2,939 13.2 2,840 13.0 2,732 12.8 2,581 12.4 2,128 10.4
55–59 2,840 13.1 2,996 13.7 2,972 13.5 2,925 13.3 2,772 12.7
60–64 2,159 11.4 2,415 12.4 2,490 12.5 2,522 12.4 2,546 12.4
≥65 2,723 5.7 3,088 6.3 3,393 6.7 3,628 6.9 3,835 7.1
Race/ethnicity        
American Indian/Alaska Native 61 2.6 47 2.0 46 1.9 48 2.0 51 2.1
Asiand 81 0.5 101 0.6 88 0.5 85 0.5 95 0.5
Black/African American 7,129 17.9 7,246 18.0 7,197 17.7 6,978 17.1 6,633 16.1
Hispanic/Latinoe 2,518 4.5 2,628 4.6 2,688 4.6 2,821 4.7 2,703 4.5
Native Hawaiian/other Pacific Islander 7 1.3 14 2.5 9 1.6 13 2.2 14 2.3
White 5,022 2.5 5,320 2.7 5,254 2.7 5,147 2.6 4,922 2.5
Multiracial 1,031 15.7 1,030 15.3 1,074 15.5 1,085 15.3 1,043 14.3
Transmission categoryf  
Male adult or adolescentg 
Male-to-male sexual contact 6,566 6,897 7,005 6,876 6,855
Injection drug use 2,288 2,272 2,168 2,187 1,965
Male-to-male sexual contact
and injection drug use
1,400 1,397 1,370 1,427 1,304
Heterosexual contacth 1,597 1,692 1,711 1,589 1,614
Perinatali 28 40 41 51 39
Otherj 76 62 66 57 58
Subtotal 11,956 9.1 12,361 9.4 12,361 9.3 12,187 9.1 11,834 8.8
Female adult or adolescentg
Injection drug use 1,353 1,384 1,373 1,319 1,221
Heterosexual contacth 2,468 2,567 2,551 2,607 2,352
Perinatali 46 48 43 36 35
Otherj 28 26 28 27 21
Subtotal 3,895 2.8 4,026 2.9 3,995 2.9 3,989 2.8 3,629 2.6
Child (<13 yrs at death)
Perinatal 2 1 2 1 1
Otherj 2 1 0 0 1
Subtotal 4 0.0 2 0.0 2 0.0 1 0.0 2 0.0
Region of residencek          
Northeast 3,613 6.4 3,711 6.6 3,699 6.6 3,535 6.3 3,450 6.2
Midwest 1,821 2.7 1,858 2.7 1,911 2.8 2,000 2.9 1,850 2.7
South 7,812 6.5 8,056 6.6 8,009 6.5 7,848 6.3 7,518 6.0
West 2,609 3.4 2,764 3.6 2,739 3.5 2,794 3.6 2,647 3.4
Totall 15,855 4.9 16,389 5.1 16,358 5.0 16,177 5.0 15,465 4.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
eHispanic/Latino persons can be of any race.
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals  ≥13 years of age at time of diagnosis of HIV infection.
jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.
lIncludes persons whose race/ethnicity is unknown.

Table 11b. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 12,152 12,565 12,557 12,361 11,970
Female 3,998 4,120 4,100 4,062 3,705
Transgender male-to-femaleb 108 121 106 120 136
Transgender female-to-maleb 5 2 4 3 5
Additional gender identityc 1 0 1 1 1
Age at death (yr)
<13 4 0.0 2 0.0 2 0.0 1 0.0 2 0.0
13–14 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0
15–19 11 0.1 11 0.1 7 0.0 9 0.0 11 0.1
20–24 152 0.7 160 0.7 145 0.7 125 0.6 118 0.5
25–29 404 1.8 454 2.0 452 1.9 426 1.8 410 1.7
30–34 612 2.8 667 3.0 616 2.8 621 2.8 648 2.9
35–39 837 4.1 867 4.1 882 4.1 833 3.8 818 3.7
40–44 1,260 6.2 1,162 5.8 1,003 5.1 981 4.9 917 4.6
45–49 2,052 9.8 1,860 8.8 1,790 8.5 1,637 7.8 1,370 6.6
50–54 3,034 13.5 2,912 13.2 2,809 13.0 2,632 12.5 2,201 10.6
55–59 2,907 13.2 3,071 13.8 3,053 13.8 2,996 13.5 2,824 12.8
60–64 2,207 11.5 2,469 12.5 2,532 12.6 2,571 12.5 2,596 12.5
≥65 2,784 5.8 3,172 6.4 3,477 6.8 3,715 7.0 3,901 7.1
Race/ethnicity
AmericanIndian/Alaska Native 61 47 46 48 51
Asiand 82 101 88 85 95
Black/AfricanAmerican 7,135 7,255 7,202 6,978 6,634
Hispanic/Latinoe 2,918 3,034 3,092 3,185 3,048
NativeHawaiian/other Pacific Islander 8 16 9 16 17
White 5,022 5,321 5,255 5,148 4,923
Multiracial 1,032 1,031 1,074 1,087 1,045
Transmissioncategoryf
Male adult or adolescentg
Male-to-male sexual contact 6,645 6,976 7,077 6,957 6,926
Injection drug use 2,421 2,403 2,299 2,309 2,085
Male-to-male sexual contact and injection drug use 1,429 1,428 1,395 1,448 1,327
Heterosexual contacth 1,656 1,769 1,784 1,651 1,668
Perinatali 29 46 42 57 41
Otherj 78 62 66 58 58
Subtotal 12,258 9.3 12,685 9.5 12,663 9.4 12,481 9.2 12,105 8.9
Female adult or adolescentg
Injection drug use 1,377 1,419 1,408 1,352 1,251
Heterosexual contacth 2,549 2,624 2,623 2,648 2,401
Perinatali 47 50 44 38 36
Otherj 28 27 28 27 22
Subtotal 4,002 2.9 4,121 2.9 4,103 2.9 4,065 2.9 3,710 2.6
Child (<13 yrs at death)
Perinatal 2 1 2 1 1
Otherj 2 1 0 0 1
Subtotal 4 0.0 2 0.0 2 0.0 1 0.0 2 0.0
Regionof residencek
Northeast 3,613 6.4 3,711 6.6 3,699 6.6 3,535 6.3 3,450 6.2
Midwest 1,821 2.7 1,858 2.7 1,911 2.8 2,000 2.9 1,850 2.7
South 7,812 6.5 8,056 6.6 8,009 6.5 7,848 6.3 7,518 6.0
West 2,609 3.4 2,764 3.6 2,739 3.5 2,794 3.6 2,647 3.4
U.S. dependent areas 409 10.6 419 11.0 410 11.0 370 10.3 352 9.8
Totall 16,264 5.0 16,808 5.1 16,768 5.1 16,547 5.0 15,817 4.8

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b”Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
eHispanic/Latino persons can be of any race.
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals  ≥13 years of age at time of diagnosis of HIV infection.
jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.
lIncludes persons whose race/ethnicity is unknown.

Table 12a. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2019—United States
American Indian/Alaska Native Asiana Black/African American Hispanic/Latinob Native Hawaiian/other Pacific Islander White Multiracial Totalc
No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated
Gender
Male 32 88 4,485 2,116 9 4,197 771 11,701
Female 18 6 2,082 553 5 703 256 3,624
Transgender male-to-femalee 1 1 64 32 0 21 15 134
Transgender female-to-malee 0 0 1 2 0 1 1 5
Additional gender identityf 0 0 1 0 0 0 0 1
Age at death (yr)
<13 0 0.0 0 0.0 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0 2 0.0
13–14 0 0.0 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0 0 0.0 1 0.0
15–19 0 0.0 0 0.0 4 0.1 2 0.0 0 0.0 3 0.0 2 0.3 11 0.1
20–24 0 0.0 2 0.2 64 2.1 26 0.5 0 0.0 19 0.2 5 0.7 116 0.5
25–29 3 1.5 1 0.1 213 6.1 70 1.4 0 0.0 91 0.7 25 4.3 403 1.7
30–34 4 2.3 7 0.4 320 10.6 135 2.9 1 1.9 140 1.1 29 6.6 636 2.8
35–39 5 3.1 9 0.6 355 12.8 185 4.1 2 4.1 188 1.5 57 15.1 801 3.7
40–44 5 3.5 10 0.7 405 16.0 172 4.1 0 0.0 220 1.9 68 22.1 880 4.4
45–49 5 3.5 10 0.7 585 22.8 257 6.7 1 2.7 382 3.1 94 34.1 1,334 6.5
50–54 9 6.2 15 1.2 834 32.9 405 12.2 4 11.4 715 5.5 146 61.4 2,128 10.4
55–59 9 5.7 15 1.3 1,117 42.8 484 17.0 2 5.8 938 6.3 207 88.1 2,772 12.7
60–64 2 1.4 10 1.0 1,140 48.7 383 17.2 1 3.5 836 5.7 173 84.8 2,546 12.4
≥65 9 3.0 16 0.6 1,595 32.0 583 12.6 3 5.0 1,390 3.4 236 55.0 3,835 7.1
Transmission categoryg
Male adult or adolescenth
Male-to-male sexual contact 19 65 2,159 1,159 7 3,043 401 6,855
Injection drug use 4 6 920 473 1 406 155 1,965
Male-to-male sexual contact
and injection drug use
7 7 394 272 1 495 127 1,304
Heterosexual contacti 4 10 1,041 224 0 242 93 1,614
Perinatalj 0 0 20 10 0 3 6 39
Otherk 0 2 16 9 0 28 4 58
Subtotal 33 3.4 89 1.2 4,550 28.4 2,147 9.1 9 3.7 4,218 5.0 785 33.3 11,834 8.8
Female adult or adolescenth
Injection drug use 6 0 579 219 0 319 98 1,221
Heterosexual contacti 12 5 1,476 328 5 374 152 2,352
Perinatalj 0 0 17 8 0 5 4 35
Otherk 0 0 11 0 0 6 3 21
Subtotal 18 1.8 6 0.1 2,083 11.6 555 2.4 5 2.0 704 0.8 257 10.3 3,629 2.6
Child (<13 yrs at death)
Perinatal 0 0 0 1 0 0 0 1
Otherk 0 0 0 0 0 0 1 1
Subtotal 0 0.0 0 0.0 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0 2 0.0
Region of residencel
Northeast 1 0.8 19 0.5 1,348 21.2 981 11.8 1 4.6 742 2.0 357 36.3 3,450 6.2
Midwest 4 1.0 5 0.2 811 11.3 150 2.7 1 2.7 751 1.5 128 9.2 1,850 2.7
South 16 2.0 21 0.5 4,043 16.8 916 4.0 1 1.0 2,116 3.0 402 16.5 7,518 6.0
West 30 2.8 50 0.6 431 11.9 656 2.8 11 2.5 1,313 3.4 156 6.3 2,647 3.4
Total 51 2.1 95 0.5 6,633 16.1 2,703 4.5 14 2.3 4,922 2.5 1,043 14.3 15,465 4.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.
Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
bHispanic/Latino persons can be of any race.
cIncludes persons whose race/ethnicity is unknown.
dRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
eTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
fAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
gData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
hData presented based on sex at birth and includes transgender persons.
iHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
jIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
kIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
lData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 12b. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2019—United States and 6 dependent areas
  American Indian/Alaska Native Asiana Black/African American Hispanic/Latinob Native Hawaiian/other Pacific Islander White Multiracial Totalc
  No. No. No. No. No. No. No. No.
Gender
Male 32 88 4,486 2,379 12 4,198 772 11,970
Female 18 6 2,082 633 5 703 257 3,705
Transgender male-to-femaled 1 1 64 34 0 21 15 136
Transgender female-to-maled 0 0 1 2 0 1 1 5
Additional gender identitye 0 0 1 0 0 0 0 1
Age at death (yr)
<13 0 0 0 1 0 0 1 2
13–14 0 0 1 0 0 0 0 1
15–19 0 0 4 2 0 3 2 11
20–24 0 2 64 28 0 19 5 118
25–29 3 1 213 76 1 91 25 410
30–34 4 7 320 147 1 140 29 648
35–39 5 9 355 202 2 188 57 818
40–44 5 10 406 207 1 220 68 917
45–49 5 10 585 292 1 383 94 1,370
50–54 9 15 834 476 4 715 148 2,201
55–59 9 15 1,117 535 3 938 207 2,824
60–64 2 10 1,140 433 1 836 173 2,596
≥65 9 16 1,595 649 3 1,390 236 3,901
Transmission categoryf    
Male adult or adolescentg
Male-to-male sexual contact 19 65 2,159 1,228 8 3,043 402 6,926
Injection drug use 4 6 921 591 2 406 155 2,085
Male-to-male sexual contact
and injection drug use
7 7 394 295 1 495 127 1,327
Heterosexual contacth 4 10 1,041 277 0 243 93 1,668
Perinatali 0 0 20 12 0 3 6 41
Otherj 0 2 16 9 0 28 4 58
Subtotal 33 89 4,551 2,412 12 4,219 786 12,105
Female adult or adolescentg
Injection drug use 6 0 579 249 0 319 98 1,251
Heterosexual contacth 12 5 1,476 376 5 374 153 2,401
Perinatali 0 0 17 9 0 5 4 36
Otherj 0 0 11 1 0 6 3 22
Subtotal 18 6 2,083 635 5 704 258 3,710
Child (<13 yrs at death)
Perinatal 0 0 0 1 0 0 0 1
Otherj 0 0 0 0 0 0 1 1
Subtotal 0 0 0 1 0 0 1 2
Region of residencek
Northeast 1 19 1,348 981 1 742 357 3,450
Midwest 4 5 811 150 1 751 128 1,850
South 16 21 4,043 916 1 2,116 402 7,518
West 30 50 431 656 11 1,313 156 2,647
U.S. dependent areas 0 0 1 345 3 1 2 352
Total 51 95 6,634 3,048 17 4,923 1,045 15,817

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.
Numbers less than 12 should be interpreted with caution.

aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
bHispanic/Latino persons can be of any race.
cIncludes persons whose race/ethnicity is unknown.
dTransgender male-to-female" includes individuals who were assigned "male" sex at birth but have ever identified as "female" gender. "Transgender female-to-male" includes individuals who were assigned "female" sex at birth but have ever identified as "male" gender.
eAdditional gender identity examples include "bigender," "gender queer," and "two-spirit."
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 13a. Deaths of adults and adolescents with diagnosed HIV infection, by year of death, sex at birth, and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
Age at death (yr)
13–14 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0
15–19 6 0.1 5 0.0 5 0.0 5 0.0 9 0.1
20–24 106 0.9 112 1.0 112 1.0 95 0.9 89 0.8
25–29 314 2.8 352 3.0 348 2.9 345 2.9 342 2.8
30–34 413 3.8 477 4.3 447 4.0 460 4.1 492 4.3
35–39 544 5.4 583 5.6 628 5.9 577 5.4 579 5.3
40–44 837 8.4 743 7.6 658 6.8 624 6.4 612 6.2
45–49 1,487 14.5 1,302 12.6 1,220 11.8 1,125 11.0 938 9.3
50–54 2,227 20.4 2,130 19.9 2,042 19.5 1,901 18.5 1,586 15.7
55–59 2,182 20.7 2,336 21.9 2,250 21.1 2,252 21.1 2,158 20.3
60–64 1,674 18.4 1,846 19.9 1,935 20.3 1,905 19.6 1,971 20.0
≥65 2,166 10.3 2,474 11.4 2,716 12.1 2,898 12.4 3,057 12.7
Race/ethnicity          
American Indian/Alaska Native 44 4.7 38 4.0 32 3.3 33 3.4 33 3.4
Asianb 74 1.1 88 1.2 73 1.0 74 1.0 89 1.2
Black/African American 4,755 30.9 4,870 31.3 4,911 31.2 4,699 29.6 4,550 28.4
Hispanic/Latinoc 2,012 9.3 2,028 9.2 2,105 9.3 2,240 9.7 2,147 9.1
Native Hawaiian/other Pacific Islander 7 3.1 10 4.3 5 2.1 12 5.0 9 3.7
White 4,278 5.1 4,559 5.4 4,426 5.3 4,313 5.1 4,218 5.0
Multiracial 781 38.1 765 36.0 808 36.7 816 35.8 785 33.3
Region of residenced
Northeast 2,549 11.1 2,630 11.4 2,624 11.4 2,491 10.8 2,460 10.6
Midwest 1,460 5.3 1,476 5.3 1,510 5.4 1,594 5.7 1,488 5.3
South 5,681 11.6 5,844 11.8 5,832 11.6 5,687 11.2 5,587 10.9
West 2,266 7.3 2,411 7.6 2,395 7.5 2,415 7.5 2,299 7.1
Subtotal 11,956 9.1 12,361 9.4 12,361 9.3 12,187 9.1 11,834 8.8
Female adult or adolescent
Age at death (yr)
13–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 5 0.0 5 0.0 2 0.0 4 0.0 2 0.0
20–24 44 0.4 44 0.4 31 0.3 26 0.2 27 0.3
25–29 85 0.8 95 0.8 98 0.9 73 0.6 61 0.5
30–34 178 1.7 182 1.7 154 1.4 149 1.4 144 1.3
35–39 273 2.7 252 2.4 239 2.3 237 2.2 222 2.0
40–44 387 3.8 388 3.9 310 3.1 326 3.3 268 2.7
45–49 511 4.9 507 4.8 517 4.9 474 4.5 396 3.8
50–54 712 6.3 710 6.4 690 6.4 680 6.4 542 5.2
55–59 658 5.9 660 5.9 722 6.4 673 6.0 614 5.5
60–64 485 4.9 569 5.6 555 5.3 617 5.8 575 5.4
≥65 557 2.1 614 2.2 677 2.4 730 2.5 778 2.6
Race/ethnicity
American Indian/Alaska Native 17 1.7 9 0.9 14 1.4 15 1.5 18 1.8
Asianb 7 0.1 13 0.2 15 0.2 11 0.1 6 0.1
Black/African American 2,371 13.7 2,374 13.6 2,285 13.0 2,278 12.8 2,083 11.6
Hispanic/Latinoc 506 2.4 600 2.8 583 2.6 581 2.5 555 2.4
Native Hawaiian/other Pacific Islander 0 0.0 4 1.7 4 1.7 1 0.4 5 2.0
White 743 0.9 761 0.9 827 0.9 834 1.0 704 0.8
Multiracial 250 11.4 265 11.7 266 11.3 269 11.1 257 10.3
Region of residenced
Northeast 1,063 4.3 1,081 4.4 1,075 4.4 1,043 4.2 990 4.0
Midwest 361 1.2 381 1.3 400 1.4 406 1.4 361 1.2
South 2,129 4.1 2,211 4.2 2,176 4.1 2,161 4.0 1,930 3.6
West 342 1.1 353 1.1 344 1.1 379 1.2 348 1.1
Subtotal 3,895 2.8 4,026 2.9 3,995 2.9 3,989 2.8 3,629 2.6
Total 15,851 5.9 16,387 6.1 16,356 6.0 16,176 5.9 15,463 5.6

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 13b. Deaths of adults and adolescents with diagnosed HIV infection, by year of death, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
Age at death (yr)
13–14 0 0.0 1 0.0 0 0.0 0 0.0 1 0.0
15–19 6 0.1 6 0.1 5 0.0 5 0.0 9 0.1
20–24 108 0.9 115 1.0 113 1.0 99 0.9 91 0.8
25–29 317 2.8 358 3.0 352 2.9 352 2.9 347 2.9
30–34 425 3.9 482 4.3 457 4.1 468 4.2 498 4.3
35–39 559 5.4 608 5.8 639 6.0 590 5.4 590 5.4
40–44 864 8.5 763 7.7 686 7.0 649 6.6 638 6.4
45–49 1,526 14.7 1,344 12.8 1,262 12.1 1,152 11.1 964 9.5
50–54 2,299 20.8 2,186 20.2 2,101 19.8 1,939 18.7 1,645 16.1
55–59 2,230 20.9 2,393 22.2 2,307 21.4 2,308 21.4 2,198 20.4
60–64 1,713 18.6 1,891 20.1 1,964 20.4 1,947 19.8 2,011 20.2
≥65 2,211 10.4 2,538 11.5 2,777 12.2 2,972 12.6 3,113 12.8
Race/ethnicity
American Indian/Alaska Native 44 38 32 33 33
Asianb 74 88 73 74 89
Black/African American 4,757 4,877 4,915 4,699 4,551
Hispanic/Latinoc 2,310 2,343 2,402 2,530 2,412
Native Hawaiian/other Pacific Islander 8 11 5 13 12
White 4,278 4,559 4,427 4,314 4,219
Multiracial 782 766 808 818 786
Region of residenced
Northeast 2,549 11.1 2,630 11.4 2,624 11.4 2,491 10.8 2,460 10.6
Midwest 1,460 5.3 1,476 5.3 1,510 5.4 1,594 5.7 1,488 5.3
South 5,681 11.6 5,844 11.8 5,832 11.6 5,687 11.2 5,587 10.9
West 2,266 7.3 2,411 7.6 2,395 7.5 2,415 7.5 2,299 7.1
US dependent areas 302 19.4 324 21.1 302 20.0 294 20.0 271 18.3
Subtotal 12,258 9.3 12,685 9.5 12,663 9.4 12,481 9.2 12,105 8.9
Female adult or adolescent
Age at death (yr)
13–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 5 0.0 5 0.0 2 0.0 4 0.0 2 0.0
20–24 44 0.4 45 0.4 32 0.3 26 0.2 27 0.3
25–29 87 0.8 96 0.8 100 0.9 74 0.6 63 0.5
30–34 187 1.7 185 1.7 159 1.4 153 1.4 150 1.3
35–39 278 2.7 259 2.5 243 2.3 243 2.2 228 2.1
40–44 396 3.9 399 4.0 317 3.2 332 3.3 279 2.8
45–49 526 5.0 516 4.8 528 4.9 485 4.6 406 3.9
50–54 735 6.4 726 6.5 708 6.4 693 6.5 556 5.3
55–59 677 6.0 678 5.9 746 6.5 688 6.0 626 5.5
60–64 494 4.9 578 5.6 568 5.4 624 5.8 585 5.4
≥65 573 2.1 634 2.3 700 2.4 743 2.5 788 2.6
Race/ethnicity        
American Indian/Alaska Native 17 9 14 15 18
Asianb 8 13 15 11 6
Black/African American 2,375 2,376 2,286 2,278 2,083
Hispanic/Latinoc 608 691 690 655 635
Native Hawaiian/other Pacific Islander 0 5 4 3 5
White 743 762 827 834 704
Multiracial 250 265 266 269 258
Region of residenced
Northeast 1,063 4.3 1,081 4.4 1,075 4.4 1,043 4.2 990 4.0
Midwest 361 1.2 381 1.3 400 1.4 406 1.4 361 1.2
South 2,129 4.1 2,211 4.2 2,176 4.1 2,161 4.0 1,930 3.6
West 342 1.1 353 1.1 344 1.1 379 1.2 348 1.1
US dependent areas 107 6.2 95 5.6 108 6.4 76 4.6 81 4.9
Subtotal 4,002 2.9 4,121 2.9 4,103 2.9 4,065 2.9 3,710 2.6
Total 16,260 6.0 16,806 6.1 16,766 6.1 16,546 6.0 15,815 5.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 14a. Deaths of transgender adults and adolescents with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-female adult or adolescenta
Age at death (yr)
13–14 0 0 0 0 0
15–19 0 0 0 0 0
20–24 5 1 2 1 5
25–29 11 10 8 12 13
30–34 14 10 7 9 18
35–39 7 13 15 13 16
40–44 15 12 13 12 16
45–49 13 22 18 13 15
50–54 13 13 10 18 17
55–59 12 17 18 18 16
60–64 6 11 7 11 11
≥65 12 12 6 12 7
Race/ethnicity     
American Indian/Alaska Native 1 0 0 2 1
Asianb 0 3 0 2 1
Black/African American 53 55 43 45 64
Hispanic/Latinoc 29 28 35 35 32
Native Hawaiian/other Pacific Islander 1 1 1 0 0
White 13 22 17 21 21
Multiracial 11 12 8 14 15
Region of residenced
Northeast 25 27 24 33 39
Midwest 20 12 11 11 18
South 37 41 39 42 49
West 26 41 30 33 28
Subtotal 108 121 104 119 134
Transgender female-to-male adult or adolescenta
Age at death (yr)     
13–14 0 0 0 0 0
15–19 0 0 0 0 0
20–24 0 0 0 0 0
25–29 1 0 0 0 1
30–34 1 0 0 0 0
35–39 0 2 0 0 0
40–44 1 0 0 0 0
45–49 1 0 1 2 0
50–54 1 0 0 0 1
55–59 0 0 2 1 1
60–64 0 0 0 0 2
≥65 0 0 1 0 0
Race/ethnicity     
American Indian/Alaska Native 0 0 0 0 0
Asianb 0 0 0 0 0
Black/African American 2 1 3 0 1
Hispanic/Latinoc 2 0 0 1 2
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 1 1 0 1 1
Multiracial 0 0 1 1 1
Region of residenced
Northeast 2 0 0 0 1
Midwest 0 0 0 0 1
South 1 2 3 2 3
West 2 0 1 1 0
Subtotal 5 2 4 3 5
Total 113 123 108 122 139

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution. Additional gender identity not included due to small numbers.

a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on residence at the time of death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 14b. Deaths of transgender adults and adolescents with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States and dependent areas
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-femalea
Age at death (yr)
13–14 0 0 0 0 0
15–19 0 0 0 0 0
20–24 5 1 2 1 5
25–29 11 10 8 12 13
30–34 14 10 7 9 18
35–39 7 13 16 13 16
40–44 15 12 13 12 16
45–49 13 22 18 13 16
50–54 13 13 11 18 17
55–59 12 17 18 18 16
60–64 6 11 7 11 11
≥65 12 12 6 13 8
Race/ethnicity
American Indian/Alaska Native 1 0 0 2 1
Asianb 0 3 0 2 1
Black/African American 53 55 43 45 64
Hispanic/Latinoc 29 28 37 36 34
Native Hawaiian/other Pacific Islander 1 1 1 0 0
White 13 22 17 21 21
Multiracial 11 12 8 14 15
Region of residenced
Northeast 25 27 24 33 39
Midwest 20 12 11 11 18
South 37 41 39 42 49
West 26 41 30 33 28
US dependent areas 0 0 2 1 2
Subtotal 108 121 106 120 136
Transgender female-to-male adult or adolescenta
Age at death (yr)
13–14 0 0 0 0 0
15–19 0 0 0 0 0
20–24 0 0 0 0 0
25–29 1 0 0 0 1
30–34 1 0 0 0 0
35–39 0 2 0 0 0
40–44 1 0 0 0 0
45–49 1 0 1 2 0
50–54 1 0 0 0 1
55–59 0 0 2 1 1
60–64 0 0 0 0 2
≥65 0 0 1 0 0
Race/ethnicity
American Indian/Alaska Native 0 0 0 0 0
Asianb 0 0 0 0 0
Black/African American 2 1 3 0 1
Hispanic/Latinoc 2 0 0 1 2
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 1 1 0 1 1
Multiracial 0 0 1 1 1
Region of residenced
Northeast 2 0 0 0 1
Midwest 0 0 0 0 1
South 1 2 3 2 3
West 2 0 1 1 0
US dependent areas 0 0 0 0 0
Subtotal 5 2 4 3 5
Total 113 123 110 123 141

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution.
Additional gender identity not included due to small numbers.

a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on residence at time of death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 15a. Persons living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 713,646 733,544 752,770 771,422 789,662
Female 228,294 232,297 236,243 239,866 243,651
Transgender male-to-femaleb 8,942 9,481 9,976 10,479 11,002
Transgender female-to-maleb 318 337 369 418 461
Additional gender identityc 135 148 164 182 201
Age at end of year
<13 2,346 4.4 2,227 4.2 2,074 3.9 1,915 3.6 1,693 3.2
13–14 723 8.8 676 8.2 666 8.0 664 8.0 645 7.7
15–19 4,955 23.5 4,626 21.9 4,523 21.4 4,334 20.6 4,213 20.0
20–24 30,777 135.8 29,778 133.3 28,381 128.8 26,932 123.5 25,924 119.8
25–29 65,075 290.4 68,285 298.0 70,344 301.5 70,799 301.1 69,226 294.5
30–34 75,747 350.2 79,094 362.5 82,744 377.2 87,666 396.7 93,126 415.2
35–39 86,794 427.5 89,487 430.7 91,756 433.2 93,609 434.7 95,543 439.5
40–44 101,210 502.7 97,262 494.2 95,971 490.2 96,638 491.0 98,174 492.8
45–49 142,256 685.1 136,118 651.0 130,043 622.2 123,345 595.3 117,195 574.5
50–54 166,105 746.5 166,455 763.6 162,921 763.7 157,654 755.8 150,916 737.0
55–59 127,571 587.0 135,750 618.7 144,391 657.9 152,829 697.3 160,272 732.6
60–64 79,142 416.3 87,512 449.9 96,068 482.1 104,220 513.2 112,247 545.7
≥65 68,634 144.0 78,537 159.6 89,640 176.6 101,762 194.3 115,803 214.2
Race/ethnicity          
American Indian/Alaska Native 2,584 109.0 2,755 115.3 2,919 121.4 3,055 126.2 3,215 132.0
Asiand 12,060 70.1 12,978 73.3 13,923 76.6 14,792 79.8 15,558 82.3
Black/African American 385,270 966.5 395,101 982.1 404,466 997.0 413,501 1,012.0 422,781 1,027.5
Hispanic/Latinoe 215,383 382.9 223,904 389.7 232,464 396.9 240,936 404.0 249,114 411.3
Native Hawaiian/other Pacific Islander 738 133.2 764 135.1 806 139.8 859 146.5 912 153.0
White 286,029 144.6 290,628 146.9 295,121 149.2 299,436 151.6 303,701 153.9
Multiracial 48,519 739.9 48,929 725.3 49,077 708.4 49,042 690.7 48,954 673.1
Transmission categoryf
Male adult or adolescentg
Male-to-male sexual contact 512,699 532,283 551,337 569,690 587,555
Injection drug use 70,420 69,445 68,695 68,046 67,603
Male-to-male sexual contact
and injection drug use
56,302 56,429 56,525 56,545 56,719
Heterosexual contacth 74,746 76,433 77,740 79,170 80,351
Perinatali 4,618 4,709 4,800 4,891 5,002
Otherj 2,824 2,805 2,812 2,802 2,804
Subtotal 721,610 551.2 742,105 561.9 761,910 572.3 781,144 582.7 800,035 592.8
Female adult or adolescentg
Injection drug use 49,481 49,148 48,914 48,733 48,660
Heterosexual contacth 171,086 175,360 179,492 183,273 187,127
Perinatali 5,170 5,302 5,455 5,610 5,743
Otherj 1,642 1,665 1,677 1,692 1,720
Subtotal 227,379 166.0 231,475 167.6 235,538 169.2 239,308 170.8 243,249 172.5
Child (<13 yrs at end of year)
Perinatal 1,926 1,824 1,698 1,544 1,366
Otherj 420 403 376 371 327
Subtotal 2,346 4.4 2,227 4.2 2,074 3.9 1,915 3.6 1,693 3.2
Region of residencek
Northeast 226,458 404.1 230,557 411.4 232,575 414.9 234,657 418.7 236,502 422.5
Midwest 112,605 165.9 116,258 171.0 119,404 175.3 122,532 179.6 125,214 183.3
South 426,978 352.9 437,447 357.5 450,412 364.6 462,663 371.4 475,547 378.7
West 185,294 244.6 191,545 250.2 197,131 255.2 202,515 260.2 207,714 265.1
Totall 951,335 296.7 975,807 302.2 999,522 307.6 1,022,367 312.9 1,044,977 318.4

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
eHispanic/Latino persons can be of any race.
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
jncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on address of residence at the end of the specified year (i.e., most recent known address).
lIncludes persons whose race/ethnicity is unknown.

Table 15b. Persons living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 725,350 745,270 764,355 782,922 801,239
Female 233,453 237,406 241,216 244,782 248,548
Transgender male-to-femaleb 8,974 9,513 10,007 10,507 11,032
Transgender female-to-maleb 319 338 370 419 462
Additional gender identityc 135 148 164 182 201
Age at end of year          
<13 2,359 4.4 2,241 4.2 2,083 3.9 1,921 3.6 1,698 3.2
13–14 729 8.7 679 8.2 672 8.0 672 8.0 649 7.7
15–19 5,024 23.5 4,674 21.8 4,568 21.4 4,375 20.5 4,238 19.9
20–24 31,172 135.8 30,128 133.2 28,679 128.6 27,196 123.3 26,168 119.6
25–29 65,845 290.6 69,045 298.1 71,051 301.3 71,498 301.0 69,910 294.3
30–34 76,720 350.9 80,063 363.2 83,660 377.7 88,543 397.0 94,024 415.3
35–39 88,253 429.5 90,893 432.5 93,042 434.6 94,789 435.9 96,626 440.2
40–44 103,000 505.4 98,945 496.8 97,572 492.6 98,175 493.3 99,644 494.7
45–49 144,873 689.4 138,539 654.8 132,237 625.5 125,329 598.2 119,071 577.2
50–54 169,190 751.5 169,494 768.5 165,865 768.4 160,486 760.5 153,530 741.1
55–59 130,034 591.6 138,323 623.4 147,049 662.6 155,577 702.0 163,186 737.7
60–64 80,716 419.6 89,252 453.6 97,925 485.8 106,246 517.4 114,383 549.9
≥65 70,316 145.5 80,399 161.2 91,709 178.3 104,005 196.0 118,355 216.0
Race/ethnicity          
American Indian/Alaska Native 2,586 2,757 2,921 3,057 3,217
Asiand 12,111 13,030 13,979 14,853 15,624
Black/African American 385,592 395,413 404,773 413,817 423,101
Hispanic/Latinoe 231,772 240,271 248,545 256,864 265,083
Native Hawaiian/other Pacific Islander 765 795 842 894 947
White 286,110 290,708 295,204 299,517 303,793
Multiracial 48,540 48,950 49,099 49,061 48,972
Transmission categoryf
Male adult or adolescentg
Male-to-male sexual contact 517,273 537,017 556,104 574,555 592,579
Injection drug use 74,156 73,075 72,201 71,424 70,883
Male-to-male sexual contact and injection drug use 57,159 57,255 57,312 57,300 57,468
Heterosexual contacth 77,145 78,835 80,133 81,541 82,745
Perinatali 4,756 4,842 4,932 5,022 5,134
Otherj 2,851 2,831 2,839 2,827 2,831
Subtotal 733,340 553.6 753,856 564.3 773,521 574.5 792,669 584.9 811,640 594.9
Female adult or adolescentg          
Injection drug use 50,563 50,200 49,909 49,693 49,607
Heterosexual contacth 175,013 179,270 183,329 187,097 190,957
Perinatali 5,301 5,431 5,580 5,729 5,850
Otherj 1,655 1,677 1,689 1,703 1,730
Subtotal 232,532 167.6 236,578 169.2 240,508 170.7 244,222 172.3 248,144 173.9
Child (<13 yrs at end of year)
Perinatal 1,939 1,838 1,707 1,550 1,371
Otherj 420 403 376 371 327
Subtotal 2,359 4.4 2,241 4.2 2,083 3.9 1,921 3.6 1,698 3.2
Region of residencek
Northeast 226,458 404.1 230,557 411.4 232,575 414.9 234,657 418.7 236,502 422.5
Midwest 112,605 165.9 116,258 171.0 119,404 175.3 122,532 179.6 125,214 183.3
South 426,978 352.9 437,447 357.5 450,412 364.6 462,663 371.4 475,547 378.7
West 185,294 244.6 191,545 250.2 197,131 255.2 202,515 260.2 207,714 265.1
U.S. dependent areas 16,896 436.1 16,868 443.1 16,590 445.4 16,445 457.8 16,505 459.5
Totall 968,231 298.4 992,675 303.8 1,016,112 309.1 1,038,812 314.5 1,061,482 319.9

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
eHispanic/Latino persons can be of any race.
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on address of residence at the end of the specified year (i.e., most recent known address).
lIncludes persons whose race/ethnicity is unknown.

Table 16a. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2019—United States
American Indian/Alaska Native Asiana Black/African American Hispanic/Latinob Native Hawaiian/other Pacific Islander White Multiracial Totalc
No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated
Gender
Male 2,353 12,655 276,346 197,849 735 262,519 36,670 789,662
Female 805 2,713 141,111 47,309 143 39,931 11,432 243,651
Transgender male-to-femalee 52 176 5,040 3,800 34 1,108 792 11,002
Transgender female-to-malee 4 9 206 100 0 107 35 461
Additional gender identityf 1 5 78 56 0 36 25 201
Age at end of year
<13 6 1.4 108 4.1 1,003 14.0 225 1.7 2 1.9 214 0.8 135 5.6 1,693 3.2
13–14 1 1.4 30 7.1 412 36.4 83 3.9 1 5.9 77 1.8 41 12.2 645 7.7
15–19 12 6.8 96 8.7 2,508 86.6 939 18.6 5 12.1 482 4.4 170 22.5 4,213 20.0
20–24 112 61.6 411 32.7 14,142 462.1 6,601 136.3 25 58.1 3,598 31.1 1,030 153.1 25,924 119.8
25–29 269 134.0 1,240 78.7 34,525 988.4 18,259 369.7 84 165.2 11,560 91.3 3,281 561.7 69,226 294.5
30–34 354 202.2 1,665 100.2 43,060 1,422.7 25,056 546.3 112 215.2 18,209 145.8 4,662 1,055.6 93,126 415.2
35–39 391 245.7 1,822 113.8 39,455 1,417.2 27,485 609.4 129 261.6 21,505 175.4 4,749 1,260.3 95,543 439.5
40–44 332 233.3 1,971 136.4 39,350 1,552.9 28,381 684.4 108 264.8 23,201 205.2 4,811 1,560.2 98,174 492.8
45–49 392 275.0 2,426 171.9 45,441 1,770.8 31,197 817.6 108 289.5 32,069 264.0 5,511 2,001.7 117,195 574.5
50–54 447 308.0 2,031 169.1 56,018 2,207.4 36,435 1,099.9 111 316.6 48,407 372.1 7,350 3,088.7 150,916 737.0
55–59 415 264.2 1,517 135.8 58,674 2245.8 32,801 1151.5 99 288.3 59,083 397.3 7,510 3,196.5 160,272 732.6
60–64 250 177.2 1,012 100.9 43,946 1877.3 20,970 941.1 64 221.0 40,841 279.3 5,027 2,462.8 112,247 545.7
≥65 234 77.6 1,229 49.3 44,247 888.6 20,682 445.8 64 105.9 44,455 108.0 4,677 1,090.2 115,803 214.2
Transmission categoryg
Male adult or adolescenth
Male-to-male sexual contact 1,690 10,803 181,186 150,046 657 215,558 27,250 587,555
Injection drug use 236 436 31,382 19,436 24 13,411 2,604 67,603
Male-to-male sexual contact and injection drug use 293 393 15,268 13,730 44 22,774 4,167 56,719
Heterosexual contacti 165 1,031 49,511 16,704 38 9,922 2,951 80,351
Perinatalj 5 57 2,822 1,234 3 554 319 5,002
Otherk 14 71 795 445 1 1,340 132 2,804
Subtotal 2,403 246.7 12,790 166.7 280,963 1,752.4 201,595 852.0 768 312.2 2,63,558 313.7 37,423 1586.6 800,035 592.8
Female adult or adolescenth
Injection drug use 270 187 22,915 9,804 22 12,538 2,856 48,660
Heterosexual contacti 517 2,350 113,741 35,871 119 26,295 8,111 187,127
Perinatalj 9 53 3,363 1,345 0 615 350 5,743
Otherk 11 70 796 274 1 482 79 1,720
Subtotal 806 79.0 2,660 30.8 140,815 785.4 47,294 202.5 142 58.1 39,929 45.7 11,396 456.4 243,249 172.5
Child (<13 yrs at end of year)
Perinatal 6 68 819 203 2 150 118 1,366
Otherk 0 40 184 22 0 64 17 327
Subtotal 6 1.4 108 4.1 1,003 14.0 225 1.7 2 1.9 214 0.8 135 5.6 1,693 3.2
Region of residencel
Northeast 150 117.9 3,397 88.8 90,482 1425.7 72,891 875.3 66 300.4 54,358 149.5 14,808 1505.1 236,502 422.5
Midwest 384 92.1 1,559 65.9 53,976 751.7 15,502 279.4 51 139.2 47,785 93.0 5,837 420.2 125,214 183.3
South 789 97.3 3,121 69.0 245,579 1022.8 90,951 394.3 154 158.7 114,971 162.8 19,824 815.1 475,547 378.7
West 1,892 175.2 7,481 91.3 32,744 907.2 69,770 295.2 641 145.6 86,587 222.5 8,485 343.7 207,714 265.1
Total 3,215 132.0 15,558 82.3 422,781 1027.5 249,114 411.3 912 153.0 303,701 153.9 48,954 673.1 1,044,977 318.4

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
bHispanic/Latino persons can be of any race.
cIncludes persons whose race/ethnicity is unknown.
dRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
e“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
fAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
gData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
hData presented based on sex at birth and includes transgender persons.
iHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
jIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
kIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
lData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 16b. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2019—United States and 6 dependent areas
American Indian/Alaska Native Asiana Black/African American Hispanic/Latinob Native Hawaiian/other Pacific Islander White Multiracial Totalc
No. No. No. No. No. No. No. No.
Gender
Male 2,355 12,710 276,536 209,061 762 262,593 36,685 801,239
Female 805 2,724 141,241 52,036 150 39,949 11,435 248,548
Transgender male-to-femaled 52 176 5,040 3,829 35 1,108 792 11,032
Transgender female-to-maled 4 9 206 101 0 107 35 462
Additional gender identitye 1 5 78 56 0 36 25 201
Age at end of year
<13 6 108 1,004 228 3 214 135 1,698
13–14 1 30 412 87 1 77 41 649
15–19 12 96 2,510 961 5 482 171 4,238
20–24 112 411 14,143 6,840 26 3,600 1,031 26,168
25–29 269 1,244 34,531 18,927 89 11,561 3,281 69,910
30–34 354 1,671 43,073 25,921 118 18,216 4,663 94,024
35–39 391 1,830 39,481 28,526 133 21,507 4,751 96,626
40–44 332 1,976 39,372 29,813 111 23,208 4,812 99,644
45–49 392 2,433 45,486 33,001 112 32,080 5,514 119,071
50–54 448 2,040 56,076 38,955 115 48,425 7,354 153,530
55–59 416 1,531 58,713 35,637 103 59,101 7,512 163,186
60–64 250 1,018 43,983 23,049 65 40,853 5,027 114,383
≥65 234 1,236 44,317 23,138 66 44,469 4,680 118,355
Transmission categoryf
Male adult or adolescentg        
Male-to-male sexual contact 1,691 10,849 181,269 154,844 679 215,617 27,263 592,579
Injection drug use 236 442 31,418 22,670 25 13,414 2,604 70,883
Male-to-male sexual contact
and injection drug use
293 394 15,274 14,459 46 22,783 4,168 57,468
Heterosexual contacth 166 1,033 49,572 19,027 42 9,925 2,951 82,745
Perinatali 5 57 2,824 1,364 3 554 319 5,134
Otherj 14 71 795 472 1 1,340 132 2,831
Subtotal 2,405 12,845 281,152 212,835 796 263,632 37,438 811,640
Female adult or adolescentg
Injection drug use 270 189 22,931 10,728 22 12,543 2,856 49,607
Heterosexual contacth 517 2,358 113,849 39,563 125 26,308 8,113 190,957
Perinatali 9 54 3,367 1,448 0 615 351 5,850
Otherj 11 70 798 282 1 482 79 1,730
Subtotal 806 2,671 140,945 52,020 148 39,947 11,399 248,144
Child (<13 yrs at end of year)
Perinatal 6 68 820 206 3 150 118 1,371
Otherj 0 40 184 22 0 64 17 327
Subtotal 6 108 1,004 228 3 214 135 1,698
Region of residencek
Northeast 150 3,397 90,482 72,891 66 54,358 14,808 236,502
Midwest 384 1,559 53,976 15,502 51 47,785 5,837 125,214
South 789 3,121 245,579 90,951 154 114,971 19,824 475,547
West 1,892 7,481 32,744 69,770 641 86,587 8,485 207,714
U.S. dependent areas 2 66 320 15,969 35 92 18 16,505
Total 3,217 15,624 423,101 265,083 947 303,793 48,972 1,061,482

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution.

aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
bHispanic/Latino persons can be of any race.
cIncludes persons whose race/ethnicity is unknown.
d“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
eAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
gData presented based on sex at birth and includes transgender persons.
hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
iIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
kData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 17a. Adults and adolescents living with diagnosed HIV infection, by year, sex at birth, and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
Age at end of year
13–14 336 8.0 311 7.4 299 7.1 295 6.9 304 7.1
15–19 3,122 29.0 2,953 27.3 2,966 27.5 2,858 26.6 2,833 26.4
20–24 24,765 212.8 24,170 210.6 23,113 204.4 22,037 197.4 21,292 192.4
25–29 53,410 468.9 56,677 486.3 58,949 496.2 59,600 497.0 58,532 487.6
30–34 58,452 537.8 62,252 566.5 66,179 597.8 71,450 639.6 76,801 676.4
35–39 62,394 615.3 65,291 628.8 68,053 642.5 70,512 654.5 73,122 671.8
40–44 71,635 717.1 68,463 700.8 67,791 697.5 68,532 700.7 70,436 711.0
45–49 106,574 1,035.8 101,126 976.4 95,419 921.8 89,755 875.7 84,310 836.0
50–54 128,405 1,175.6 128,283 1197.8 1,25,078 1192.7 120,177 1170.8 114,106 1131.3
55–59 98,021 928.3 104,329 978.3 111,031 1040.5 117,735 1104.6 123,538 1160.8
60–64 61,117 672.7 67,313 724.0 73,721 773.6 79,688 819.9 85,673 869.2
≥65 53,379 253.7 60,937 279.8 69,311 307.8 78,505 337.2 89,088 370.1
Race/ethnicity
American Indian/Alaska Native 1,877 200.0 2,016 212.7 2,149 224.6 2,270 235.1 2,403 246.7
Asianb 9,823 142.6 10,574 148.6 11,389 155.4 12,140 161.9 12,790 166.7
Black/African American 251,798 1635.9 259,391 1,666.4 266,544 1,694.6 273,648 1723.3 280,963 1752.4
Hispanic/Latinoc 171,505 793.0 179,157 808.6 186,742 823.7 194,267 837.9 201,595 852.0
Native Hawaiian/other Pacific Islander 608 269.0 632 273.1 669 283.0 719 298.1 768 312.2
White 248,632 296.7 252,552 300.9 256,433 305.3 260,102 309.6 263,558 313.7
Multiracial 36,824 1796.6 37,244 1752.7 37,446 1700.9 37,460 1644.2 37,423 1586.6
Region of residenced
Northeast 158,956 691.0 162,350 704.4 164,219 711.3 166,141 718.8 167,941 726.3
Midwest 88,896 320.2 91,806 329.5 94,294 337.2 96,766 344.9 98,809 351.0
South 312,392 637.9 321,138 647.8 331,632 661.6 341,792 675.3 352,323 689.3
West 161,366 517.6 166,811 528.2 171,765 537.7 176,445 546.7 180,962 555.4
Subtotal 721,610 551.2 742,105 561.9 761,910 572.3 781,144 582.7 800,035 592.8
Female adult or adolescent
Age at end of year
13–14 387 9.6 365 9.1 367 9.0 369 9.1 341 8.4
15–19 1,833 17.8 1,673 16.2 1,557 15.1 1,476 14.3 1,380 13.4
20–24 6,012 54.5 5,608 51.6 5,268 49.1 4,895 46.0 4,632 43.8
25–29 11,665 105.9 11,608 103.1 11,395 99.5 11,199 97.2 10,694 93.0
30–34 17,295 160.7 16,842 155.5 16,565 152.5 16,216 148.4 16,325 147.4
35–39 24,400 240.1 24,196 232.7 23,703 223.9 23,097 214.7 22,421 206.6
40–44 29,575 291.6 28,799 290.6 28,180 285.9 28,106 283.9 27,738 277.0
45–49 35,682 340.7 34,992 331.6 34,624 328.2 33,590 320.9 32,885 318.9
50–54 37,700 332.7 38,172 344.3 37,843 348.9 37,477 353.7 36,810 354.3
55–59 29,550 264.5 31,421 278.6 33,360 295.9 35,094 311.7 36,734 327.0
60–64 18,025 181.6 20,199 199.0 22,347 214.9 24,532 231.7 26,574 248.0
≥65 15,255 57.3 17,600 64.2 20,329 72.0 23,257 80.0 26,715 89.1
Race/ethnicity
American Indian/Alaska Native 700 71.5 733 74.1 764 76.4 779 77.1 806 79.0
Asianb 2,134 27.5 2,289 28.6 2,421 29.3 2,543 30.1 2,660 30.8
Black/African American 132,019 765.0 134,346 770.6 136,657 776.2 138,711 780.8 140,815 785.4
Hispanic/Latinoc 43,557 204.7 44,452 203.8 45,450 203.4 46,419 203.0 47,294 202.5
Native Hawaiian/other Pacific Islander 127 56.7 129 56.3 134 57.2 138 57.6 142 58.1
White 37,110 42.5 37,800 43.3 38,436 44.0 39,089 44.7 39,929 45.7
Multiracial 11,523 524.8 11,517 507.7 11,468 489.3 11,421 472.1 11,396 456.4
Region of residenced
Northeast 67,085 272.3 67,837 275.2 68,027 275.7 68,236 276.4 68,306 276.7
Midwest 23,219 80.3 23,961 82.6 24,634 84.7 25,295 86.7 25,996 88.9
South 113,536 219.5 115,314 220.2 117,840 222.5 120,008 224.3 122,463 226.5
West 23,539 74.3 24,363 75.9 25,037 77.2 25,769 78.7 26,484 80.1
Subtotal 227,379 166.0 231,475 167.6 235,538 169.2 239,308 170.8 243,249 172.5
Total 948,989 354.2 973,580 360.4 997,448 366.3 1,020,452 372.2 1,043,284 378.0

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

aRates are per 100,000 population.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 17b. Adults and adolescents living with diagnosed HIV infection, by year, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Male adult or adolescent
Age at end of year
13–14 339 7.9 313 7.4 301 7.1 299 7.0 307 7.1
15–19 3,160 28.9 2,980 27.3 2,988 27.4 2,884 26.5 2,849 26.2
20–24 25,060 212.8 24,435 210.4 23,342 204.1 22,232 196.9 21,484 192.0
25–29 53,997 468.9 57,275 486.2 59,510 495.7 60,167 496.7 59,089 487.2
30–34 59,152 538.7 62,965 567.4 66,863 598.4 72,119 640.0 77,500 676.5
35–39 63,406 618.2 66,262 631.3 68,950 644.4 71,344 656.0 73,913 672.8
40–44 72,817 720.4 69,594 704.2 68,883 700.8 69,595 703.9 71,465 713.7
45–49 108,426 1041.6 102,809 981.4 96,924 926.0 91,077 879.0 85,553 839.1
50–54 130,544 1182.1 130,412 1204.2 127,156 1199.0 122,203 1,177.4 115,967 1137.0
55–59 99,695 933.9 106,066 984.0 112,852 1046.4 119,641 1,110.7 125,567 1167.5
60–64 62,230 677.2 68,540 729.0 75,028 778.7 81,073 825.2 87,120 874.5
≥65 54,514 255.6 62,205 281.8 70,724 309.9 80,035 339.3 90,826 372.4
Race/ethnicity          
American Indian/Alaska Native 1,879 2,018 2,151 2,272 2,405
Asianb 9,863 10,615 11,434 12,190 12,845
Black/African American 251,985 259,572 266,722 273,836 281,152
Hispanic/Latinoc 182,905 190,579 198,015 205,443 212,835
Native Hawaiian/other Pacific Islander 626 655 697 748 796
White 248,697 252,616 256,498 260,166 263,632
Multiracial 36,840 37,260 37,464 37,474 37,438
Region of residenced
Northeast 158,956 691.0 162,350 704.4 164,219 711.3 166,141 718.8 167,941 726.3
Midwest 88,896 320.2 91,806 329.5 94,294 337.2 96,766 344.9 98,809 351.0
South 312,392 637.9 321,138 647.8 331,632 661.6 341,792 675.3 352,323 689.3
West 161,366 517.6 166,811 528.2 171,765 537.7 176,445 546.7 180,962 555.4
U.S. dependent areas 11,730 752.9 11,751 764.8 11,611 767.5 11,525 783.1 11,605 785.1
Subtotal 733,340 553.6 753,856 564.3 773,521 574.5 792,669 584.9 811,640 594.9
Female adult or adolescent
Age at end of year
13–14 390 9.5 366 9.0 371 9.0 373 9.1 342 8.3
15–19 1,864 17.9 1,694 16.2 1,580 15.1 1,491 14.3 1,389 13.3
20–24 6,112 54.7 5,693 51.7 5,337 49.1 4,964 46.1 4,684 43.8
25–29 11,848 106.3 11,770 103.4 11,541 99.7 11,331 97.3 10,821 93.1
30–34 17,568 161.5 17,098 156.2 16,797 153.0 16,424 148.9 16,524 147.7
35–39 24,847 241.4 24,631 234.1 24,092 225.0 23,445 215.6 22,713 207.2
40–44 30,183 293.9 29,351 292.5 28,689 287.5 28,580 285.3 28,179 278.2
45–49 36,447 343.6 35,730 334.5 35,313 330.8 34,252 323.4 33,518 321.3
50–54 38,646 337.0 39,082 348.2 38,709 352.5 38,283 357.0 37,563 357.2
55–59 30,339 268.3 32,257 282.7 34,197 299.8 35,936 315.5 37,619 331.0
60–64 18,486 184.0 20,712 201.6 22,897 217.6 25,173 235.0 27,263 251.5
≥65 15,802 58.5 18,194 65.4 20,985 73.3 23,970 81.3 27,529 90.6
Race/ethnicity
American Indian/Alaska Native 700 733 764 779 806
Asianb 2,145 2,300 2,432 2,554 2,671
Black/African American 132,153 134,475 136,785 138,838 140,945
Hispanic/Latinoc 48,536 49,387 50,251 51,167 52,020
Native Hawaiian/other Pacific Islander 135 136 141 143 148
White 37,126 37,816 38,454 39,106 39,947
Multiracial 11,527 11,521 11,472 11,426 11,399
Region of residenced
Northeast 67,085 272.3 67,837 275.2 68,027 275.7 68,236 276.4 68,306 276.7
Midwest 23,219 80.3 23,961 82.6 24,634 84.7 25,295 86.7 25,996 88.9
South 113,536 219.5 115,314 220.2 117,840 222.5 120,008 224.3 122,463 226.5
West 23,539 74.3 24,363 75.9 25,037 77.2 25,769 78.7 26,484 80.1
U.S. dependent areas 5,153 298.1 5,103 298.4 4,970 295.2 4,914 300.2 4,895 297.4
Subtotal 232,532 167.6 236,578 169.2 240,508 170.7 244,222 172.3 248,144 173.9
Total 965,872 356.2 990,434 362.2 1,014,029 368.1 1,036,891 373.9 1,059,784 379.7

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 18a. Transgender adults and adolescents living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-femalea
Age at end of year 
13–14 0 0 0 0 0
15–19 112 94 83 60 58
20–24 805 806 754 721 689
25–29 1,670 1,775 1,816 1,806 1,723
30–34 1,414 1,535 1,740 1,932 2,172
35–39 1,190 1,333 1,423 1,529 1,639
40–44 1,054 1,068 1,091 1,161 1,236
45–49 1,057 1,061 1,056 1,071 1,116
50–54 813 874 955 1,003 999
55–59 478 539 587 664 754
60–64 233 263 301 334 367
≥65 115 131 168 196 247
Race/ethnicity
American Indian/Alaska Native 35 38 40 48 52
Asianb 133 138 155 164 176
Black/African American 4,063 4,329 4,570 4,809 5,039
Hispanic/Latinoc 3,019 3,220 3,391 3,588 3,800
Native Hawaiian/other Pacific Islander 24 25 27 30 34
White 926 960 1,011 1,046 1,108
Multiracial 741 769 780 792 791
Region of residenced
Northeast 2,406 2,604 2,723 2,861 2,964
Midwest 1,149 1,227 1,301 1,386 1,430
South 3,154 3,312 3,508 3,657 3,856
West 2,232 2,336 2,442 2,573 2,750
Subtotal 8,941 9,479 9,974 10,477 11,000
Transgender female-to-malea
Age at end of year 
13–14 1 0 0 0 0
15–19 4 6 7 6 4
20–24 18 13 17 21 29
25–29 34 40 56 68 72
30–34 49 49 42 57 78
35–39 44 50 62 64 64
40–44 43 42 40 49 53
45–49 43 42 45 49 52
50–54 38 45 46 45 42
55–59 25 26 26 23 32
60–64 10 15 19 25 21
≥65 8 8 8 10 13
Race/ethnicity
American Indian/Alaska Native 4 4 4 4 4
Asianb 2 3 6 8 9
Black/African American 155 159 168 188 206
Hispanic/Latinoc 65 71 78 88 100
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 65 70 81 97 107
Multiracial 26 29 31 32 34
Region of residenced
Northeast 65 64 69 75 82
Midwest 94 99 105 115 119
South 91 96 109 125 143
West 67 77 85 102 116
Subtotal 317 336 368 417 460
Total 9,258 9,815 10,342 10,894 11,460

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 18b. Transgender adults and adolescents living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States and 6 dependent areas
2015 2016 2017 2018 2019
No. No. No. No. No.
Transgender male-to-femalea
Age at end of year
13–14 0 0 0 0 0
15–19 113 94 83 60 58
20–24 809 810 757 724 693
25–29 1,674 1,779 1,819 1,810 1,727
30–34 1,419 1,539 1,747 1,937 2,176
35–39 1,194 1,338 1,426 1,531 1,640
40–44 1,055 1,070 1,093 1,166 1,242
45–49 1,062 1,063 1,058 1,071 1,117
50–54 817 878 958 1,004 1,002
55–59 480 543 592 669 758
60–64 233 264 302 335 369
≥65 117 133 170 198 248
Race/ethnicity
American Indian/Alaska Native 35 38 40 48 52
Asianb 133 138 155 164 176
Black/African American 4,063 4,329 4,570 4,809 5,039
Hispanic/Latinoc 3,051 3,252 3,422 3,616 3,829
Native Hawaiian/other Pacific Islander 24 25 27 30 35
White 926 960 1,011 1,046 1,108
Multiracial 741 769 780 792 791
Region of residenced
Northeast 2,406 2,604 2,723 2,861 2,964
Midwest 1,149 1,227 1,301 1,386 1,430
South 3,154 3,312 3,508 3,657 3,856
West 2,232 2,336 2,442 2,573 2,750
US dependent areas 32 32 31 28 30
Subtotal 8,973 9,511 10,005 10,505 11,030
Transgender female-to-malea
Age at end of year
13–14 1 0 0 0 0
15–19 5 7 8 7 4
20–24 18 13 17 21 30
25–29 34 40 56 68 72
30–34 49 49 42 57 78
35–39 44 50 62 64 64
40–44 43 42 40 49 53
45–49 43 42 45 49 52
50–54 38 45 46 45 42
55–59 25 26 26 23 32
60–64 10 15 19 25 21
≥65 8 8 8 10 13
Race/ethnicity
American Indian/Alaska Native 4 4 4 4 4
Asianb 2 3 6 8 9
Black/African American 155 159 168 188 206
Hispanic/Latinoc 66 72 79 89 101
Native Hawaiian/other Pacific Islander 0 0 0 0 0
White 65 70 81 97 107
Multiracial 26 29 31 32 34
Region of residenced
Northeast 65 64 69 75 82
Midwest 94 99 105 115 119
South 91 96 109 125 143
West 67 77 85 102 116
US dependent areas 1 1 1 1 1
Subtotal 318 337 369 418 461
Total 9,291 9,848 10,374 10,923 11,491

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
cHispanic/Latino persons can be of any race.
dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 19a. Adolescents and young adults living with diagnosed HIV infection, by 2-year and 3-year age groups, and selected characteristics, year-end 2019—United States
13–14 years of age at end of year 15–17 years of age at end of year 18–19 years of age at end of year 20–22 years of age at end of year 23–24 years of age at end of year Total
No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Gender
Male 304 769 2,003 8,986 11,595 23,657
Female 341 657 718 2,127 2,475 6,318
Transgender male-to-femaleb 0 5 53 313 376 747
Transgender female-to-maleb 0 0 4 21 8 33
Additional gender identityc 0 0 4 12 11 27
Race/Ethnicity
American Indian/Alaska Native 1 1.4 5 4.8 7 9.6 45 41.5 67 91.6 125 29.1
Asiand 30 7.1 52 8.0 44 9.6 171 23.9 240 44.4 537 19.3
Black/African American 412 36.4 861 51.0 1,647 136.6 6,465 357.0 7,677 614.6 17,062 240.7
Hispanic/Latinoe 83 3.9 262 8.7 677 33.6 2,842 97.6 3,759 194.4 7,623 63.6
Native Hawaiian/Other Pacific Islander 1 5.9 2 8.1 3 17.9 10 39.9 15 83.7 31 30.6
White 77 1.8 175 2.7 307 6.8 1,491 21.7 2,107 44.7 4,157 15.5
Multiracial 41 12.2 74 16.1 96 32.7 431 104.2 599 231.3 1,241 70.4
Transmission Categoryf
Males
Male-to-male sexual contact 6 262 1,615 8,058 10,494 20,435
Injection drug use 1 2 9 85 144 240
Male-to-male sexual contact and injection drug use 0 6 31 236 419 692
Heterosexual contactg 0 13 51 233 352 649
Perinatalh 243 380 305 625 533 2,086
Otheri 54 111 48 74 39 326
Subtotal 304 7.1 774 12.2 2,059 46.9 9,310 141.8 11,982 266.3 24,429 93.7
Females
Injection drug use 1 11 27 125 186 350
Heterosexual contactg 8 86 261 1,212 1,562 3,128
Perinatalh 273 446 379 752 686 2,536
Otheri 60 114 56 60 48 339
Subtotal 341 8.4 657 10.8 723 17.2 2,149 34.2 2,483 57.9 6,353 25.5
Region of Residencej
Northeast 114 8.7 265 13.1 488 33.0 1,837 84.7 2,397 165.4 5,101 60.5
Midwest 145 8.2 228 8.6 427 23.6 1,720 62.4 2,100 115.1 4,620 42.8
South 279 8.6 692 14.4 1,505 45.8 6,165 126.2 7,517 225.8 16,158 82.6
West 107 5.3 246 8.2 362 18.0 1,737 57.2 2,451 112.3 4,903 40.1
Totalk 645 7.7 1,431 11.5 2,782 32.4 11,459 89.2 14,465 164.6 30,782 60.3

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Data for the year 2019 are considered preliminary and based on death data received by CDC through December 2020.

aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
dIncludes Asian/Pacific Islander legacy cases.
eHispanic/Latino persons can be of any race.
fData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
iIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
jData are based on address of residence at the end of the specified year (i.e., most recent known address).
kIncludes persons whose race/ethnicity is unknown.

Table 19b. Adolescents and young adults living with diagnosed HIV infection, by 2-year and 3-year age groups, and selected characteristics, year-end 2019—United States and 6 dependent areas
13–14 years of age at end of year 15–17 years of age at end of year 18–19 years of age at end of year 20–22 years of age at end of year 23–24 years of age at end of year Total
No. No. No. No. No. No.
Gender
Male 307 773 2,015 9,059 11,710 23,864
Female 342 662 722 2,148 2,505 6,379
Transgender male-to-femalea 0 5 53 314 379 751
Transgender female-to-malea 0 0 4 22 8 34
Additional gender identityb 0 0 4 12 11 27
Race/Ethnicity
American Indian/Alaska Native 1 5 7 45 67 125
Asianc 30 52 44 171 240 537
Black/African American 412 863 1,647 6,466 7,677 17,065
Hispanic/Latinod 87 268 693 2,935 3,905 7,888
Native Hawaiian/Other Pacific Islander 1 2 3 11 15 32
White 77 175 307 1,492 2,108 4,159
Multiracial 41 75 96 431 600 1,243
Transmission Categorye
Males
Male-to-male sexual contact 6 262 1,622 8,108 10,586 20,585
Injection drug use 1 2 9 86 145 242
Male-to-male sexual contact and injection drug use 0 6 31 238 422 697
Heterosexual contactf 0 13 51 236 360 661
Perinatalg 246 384 310 641 545 2,126
Otherh 54 111 48 76 40 329
Subtotal 307 778 2,071 9,384 12,100 24,640
Females
Injection drug use 1 11 27 125 186 351
Heterosexual contactf 8 87 261 1,224 1,583 3,163
Perinatalg 274 450 383 759 695 2,561
Otherh 60 114 56 62 48 341
Subtotal 342 662 727 2,171 2,513 6,415
Region of Residencei
Northeast 114 265 488 1,837 2,397 5,101
Midwest 145 228 427 1,720 2,100 4,620
South 279 692 1,505 6,165 7,517 16,158
West 107 246 362 1,737 2,451 4,903
U.S. dependent areas 4 9 16 96 148 273
Totalj 649 1,440 2,798 11,555 14,613 31,055

Note: Numbers less than 12 should be interpreted with caution. Data for the year 2019 are considered preliminary and based on death data received by CDC through December 2020.

a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
bAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
cIncludes Asian/Pacific Islander legacy cases.
dHispanic/Latino persons can be of any race.
eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
iData are based on address of residence at the end of the specified year (i.e., most recent known address).
jIncludes persons whose race/ethnicity is unknown.

Table 20. Diagnoses of HIV infection, 2019, and persons living with diagnosed HIV infection (prevalence), year-end 2019, by area of residence—United States and 6 dependent areas
Diagnoses Prevalence of diagnosed HIV infection, year-end 2019
Adults and Adolescents Children Total Adults and Adolescents Children Total
Area of residence No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea No. Ratea
Alabama 638 15.5 0 0.0 638 13.0 13,875 336.4 37 4.7 13,912 283.7
Alaska 27 4.5 0 0.0 27 3.7 724 120.9 2 1.5 726 99.2
Arizona 761 12.5 2 0.2 763 10.5 17,296 283.1 34 2.9 17,330 238.1
Arkansas 287 11.4 0 0.0 287 9.5 5,939 236.0 13 2.6 5,952 197.2
California 4,354 13.1 4 0.1 4,358 11.0 132,911 401.1 105 1.6 133,016 336.6
Colorado 461 9.5 4 0.4 465 8.1 13,025 267.9 36 4.0 13,061 226.8
Connecticut 213 7.0 1 0.2 214 6.0 10,597 346.0 11 2.2 10,608 297.5
Delaware 93 11.2 0 0.0 93 9.6 3,381 408.2 5 3.4 3,386 347.7
District of Columbia 255 42.2 2 2.0 257 36.4 14,041 2,325.4 15 14.7 14,056 1991.6
Florida 4,378 23.7 6 0.2 4,384 20.4 113,478 615.0 143 4.7 113,621 529.0
Georgia 2,439 27.6 10 0.6 2,449 23.1 56,446 638.5 93 5.2 56,539 532.5
Hawaii 65 5.4 0 0.0 65 4.6 2,387 199.8 2 0.9 2,389 168.7
Idaho 28 1.9 0 0.0 28 1.6 1,234 84.0 8 2.5 1,242 69.5
Illinois 1,252 11.7 3 0.2 1,255 9.9 35,841 335.7 103 5.2 35,944 283.7
Indiana 486 8.7 2 0.2 488 7.2 11,638 207.3 58 5.2 11,696 173.7
Iowa 100 3.8 0 0.0 100 3.2 2,888 109.6 15 2.9 2,903 92.0
Kansas 131 5.4 1 0.2 132 4.5 3,174 131.6 12 2.4 3,186 109.4
Kentucky 326 8.7 2 0.3 328 7.3 7,638 203.8 15 2.1 7,653 171.3
Louisiana 881 22.8 0 0.0 881 19.0 21,289 551.4 31 3.9 21,320 458.6
Maine 30 2.6 0 0.0 30 2.2 1,649 140.9 13 7.5 1,662 123.6
Maryland 918 18.0 0 0.0 918 15.2 33,378 656.2 49 5.1 33,427 552.9
Massachusetts 535 9.0 0 0.0 535 7.8 21,065 354.6 24 2.5 21,089 306.0
Michigan 674 8.0 1 0.1 675 6.8 16,586 195.8 61 4.0 16,647 166.7
Minnesota 274 5.8 0 0.0 274 4.9 8,816 187.4 40 4.3 8,856 157.0
Mississippi 477 19.2 0 0.0 477 16.0 9,832 396.7 5 1.0 9,837 330.5
Missouri 488 9.5 0 0.0 488 8.0 12,803 248.3 30 3.1 12,833 209.1
Montana 25 2.8 0 0.0 25 2.3 669 74.0 2 1.2 671 62.8
Nebraska 81 5.1 0 0.0 81 4.2 2,236 140.6 8 2.3 2,244 116.0
Nevada 512 19.8 0 0.0 512 16.6 10,733 415.8 7 1.4 10,740 348.7
New Hampshire 31 2.6 0 0.0 31 2.3 1,306 110.4 7 4.0 1,313 96.6
New Jersey 1,057 14.1 2 0.1 1,059 11.9 35,131 468.0 47 3.4 35,178 396.1
New Mexico 156 8.9 0 0.0 156 7.4 3,734 212.2 9 2.7 3,743 178.5
New York 2,330 14.1 4 0.1 2,334 12.0 126,630 765.0 83 2.9 126,713 651.4
North Carolina 1,365 15.4 4 0.2 1,369 13.1 33,009 373.0 69 4.2 33,078 315.4
North Dakota 40 6.4 0 0.0 40 5.2 493 78.6 5 3.7 498 65.3
Ohio 980 9.9 1 0.1 981 8.4 23,179 235.3 52 2.8 23,231 198.7
Oklahoma 320 9.8 1 0.1 321 8.1 6,351 194.2 25 3.6 6,376 161.1
Oregon 199 5.5 0 0.0 199 4.7 7,280 202.4 17 2.7 7,297 173.0
Pennsylvania 989 9.0 0 0.0 989 7.7 36,494 333.9 60 3.2 36,554 285.5
Rhode Island 72 7.9 0 0.0 72 6.8 2,653 289.7 5 3.5 2,658 250.9
South Carolina 680 15.6 1 0.1 681 13.2 17,589 404.0 26 3.3 17,615 342.1
South Dakota 33 4.5 0 0.0 33 3.7 652 89.8 5 3.1 657 74.3
Tennessee 773 13.4 1 0.1 774 11.3 17,667 307.3 55 5.1 17,722 259.5
Texas 4,302 18.2 6 0.1 4,308 14.9 95,196 402.1 141 2.7 95,337 328.8
Utah 135 5.3 0 0.0 135 4.2 3,089 121.7 14 2.1 3,103 96.8
Vermont 11 2.0 0 0.0 11 1.8 722 132.7 5 6.3 727 116.5
Virginia 822 11.4 2 0.1 824 9.7 23,691 329.0 36 2.7 23,727 278.0
Washington 483 7.5 0 0.0 483 6.3 14,019 218.8 30 2.5 14,049 184.5
West Virginia 146 9.5 0 0.0 146 8.1 1,986 129.2 3 1.2 1,989 111.0
Wisconsin 211 4.3 1 0.1 212 3.6 6,499 131.9 20 2.2 6,519 112.0
Wyoming 13 2.7 0 0.0 13 2.2 345 71.5 2 2.1 347 60.0
Subtotal 36,337 13.2 61 0.1 36,398 11.1 1,043,284 378.0 1,693 3.2 1,044,977 318.4
U.S. dependent areas
American Samoa 0 0.0 0 0.0 0 0.0 1 2.6 0 0.0 1 2.0
Guam 10 7.8 0 0.0 10 5.9 107 83.8 1 2.5 108 64.2
Northern Mariana Islands 2 4.9 0 0.0 2 3.9 16 39.4 0 0.0 16 30.9
Puerto Rico 383 13.6 0 0.0 383 12.0 15,837 563.3 2 0.5 15,839 495.9
Republic of Palau 0 0.0 0 0.0 0 0.0 9 49.4 0 0.0 9 41.7
U.S. Virgin Islands 8 9.1 0 0.0 8 7.5 530 603.2 2 10.7 532 498.9
Subtotal 403 12.9 0 0.0 403 11.2 16,500 528.2 5 1.1 16,505 459.5
Total 36,740 13.2 61 0.1 36,801 11.1 1,059,784 379.7 1,698 3.2 1,061,482 319.9

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Diagnoses data are based on residence at time of diagnosis of HIV infection.
Prevalence data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

aRates are per 100,000 population.

Table 21. Adults and adolescents living with diagnosed HIV infection, by race/ethnicity and area of residence, year-end 2019—United States and 6 dependent areas
American Indian/Alaska Native Asiana Black/African American Hispanic/Latinob Native Hawaiian/other Pacific Islander White Multiracial Totalc
Area of residence No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated No. Rated
Alabama 6 24.5 39 63.7 8,767 817.7 497 319.3 3 143.8 3,722 134.9 799 1,598.1 13,875 336.4
Alaska 192 231.0 29 72.7 95 472.6 83 211.3 4 51.3 277 73.7 44 132.9 724 120.9
Arizona 674 294.7 221 102.0 2,340 876.9 5,507 308.0 26 221.4 7,905 226.3 579 558.0 17,296 283.1
Arkansas 7 35.8 25 61.7 2,592 689.5 431 250.6 6 75.6 2,576 138.3 298 778.1 5,939 236.0
California 299 215.0 5,580 108.6 21,751 1,144.8 51,551 420.8 238 193.5 48,112 376.0 5,371 682.8 132,911 401.1
Colorado 82 257.1 150 90.6 1,950 1,006.4 3,148 323.1 17 255.9 7,321 215.5 310 332.8 13,025 267.9
Connecticut 10 158.4 108 73.7 3,540 1,140.4 3,634 776.4 7 680.3 3,044 145.8 253 584.1 10,597 346.0
Delaware 3 112.9 7 21.1 1,923 1,081.4 319 464.2 1 359.7 987 186.0 140 943.3 3,381 408.2
District of Columbia 14 1,117.3 74 264.1 9,848 3757.8 1,213 1,967.0 7 2,456.1 2,102 880.6 778 6,587.6 14,041 2325.4
Florida 73 152.0 621 116.2 50,270 1,841.7 28,795 615.0 47 397.7 30,862 302.5 2,806 1,157.0 113,478 615.0
Georgia 22 104.2 273 71.1 38,693 1,400.4 4,437 573.0 16 298.1 9,998 209.8 3,000 2,351.7 56,446 638.5
Hawaii 6 223.8 391 83.5 120 515.0 310 289.4 222 199.9 1,068 391.8 270 128.5 2,387 199.8
Idaho 15 93.4 7 31.4 115 1,091.9 213 125.5 2 76.9 838 68.6 44 174.9 1,234 84.0
Illinois 31 186.1 494 78.7 16,534 1,118.2 7,372 427.4 20 658.3 9,384 140.3 2,004 1,454.0 35,841 335.7
Indiana 8 58.9 216 150.9 4,333 836.3 1,189 329.7 2 98.3 5,387 119.8 502 628.9 11,638 207.3
Iowa 5 65.0 60 86.9 655 704.2 302 211.2 3 96.4 1,703 74.5 160 483.2 2,888 109.6
Kansas 14 70.6 51 66.4 795 585.2 567 216.7 1 44.9 1,598 85.7 145 291.1 3,174 131.6
Kentucky 6 72.7 64 111.1 2,410 799.7 573 456.4 3 122.3 4,246 132.6 335 654.3 7,638 203.8
Louisiana 33 129.7 75 108.0 14,409 1,182.9 1,196 649.4 4 261.4 5,138 221.6 431 986.1 21,289 551.4
Maine 7 94.2 7 46.6 294 1,823.8 115 619.9 0 0.0 1,181 107.6 44 279.9 1,649 140.9
Maryland 20 157.6 249 72.9 23,803 1,567.4 2,428 510.5 3 119.7 4,175 158.3 2,700 2,768.2 33,378 656.2
Massachusetts 27 254.1 468 111.1 6,294 1,500.3 5,717 861.3 8 321.8 8,117 187.2 432 496.7 21,065 354.6
Michigan 32 66.3 143 50.5 9,091 807.7 1,102 276.7 2 85.1 5,611 86.8 602 398.2 16,586 195.8
Minnesota 105 227.3 177 76.4 3,212 1,128.6 1,002 436.0 5 222.2 3,890 101.6 420 514.5 8,816 187.4
Mississippi 13 107.5 24 86.7 7,209 794.5 355 481.7 2 227.3 1,827 127.3 367 1,671.4 9,832 396.7
Missouri 9 39.2 91 81.7 5,557 960.6 821 413.3 6 93.4 5,823 140.2 494 574.9 12,803 248.3
Montana 28 57.2 4 47.9 22 470.0 49 154.7 1 151.3 529 66.9 36 189.5 669 74.0
Nebraska 30 241.7 50 118.6 622 839.8 370 237.6 4 408.6 1,089 84.9 70 300.2 2,236 140.6
Nevada 50 224.3 348 152.3 2,802 1,202.9 2,851 410.1 45 272.7 4,257 324.3 378 517.2 10,733 415.8
New Hampshire 1 38.6 16 47.1 158 960.3 196 462.1 0 0.0 885 82.5 49 325.3 1,306 110.4
New Jersey 15 136.3 377 51.1 15,169 1,572.9 10,519 720.9 8 316.5 6,567 154.9 2,427 2,612.6 35,131 468.0
New Mexico 318 210.8 19 65.7 231 689.7 1,790 216.0 1 84.0 1,267 182.9 107 458.6 3,734 212.2
New York 50 102.4 2,034 137.5 47,024 1,974.2 45,350 1508.2 25 335.5 22,213 236.6 9,642 4,066.3 126,630 765.0
North Carolina 177 181.1 197 73.4 20,025 1,069.8 2,964 401.1 15 266.2 8,004 139.6 1,620 1,222.6 33,009 373.0
North Dakota 18 62.1 3 28.8 198 1,064.5 33 151.1 1 247.5 224 41.7 16 163.2 493 78.6
Ohio 12 60.7 134 55.5 10,157 848.3 1,692 486.8 4 104.0 9,970 126.5 1,108 691.2 23,179 235.3
Oklahoma 332 124.7 94 121.6 1,505 628.5 736 234.8 9 163.6 3,250 146.9 425 272.6 6,351 194.2
Oregon 57 143.7 146 83.9 548 811.9 1,129 264.0 18 126.0 5,140 185.3 242 241.3 7,280 202.4
Pennsylvania 35 219.6 312 78.0 17,170 1,497.0 6,490 862.5 16 499.7 10,630 125.5 1,837 1,315.0 36,494 333.9
Rhode Island 5 131.5 40 122.9 615 1,139.2 756 568.4 2 369.0 1,156 170.9 79 506.2 2,653 289.7
South Carolina 13 79.5 56 71.8 11,835 1,049.2 1,004 444.8 3 117.3 4,147 145.7 522 935.1 17,589 404.0
South Dakota 94 176.3 5 45.3 148 1,025.7 59 235.4 1 259.7 321 52.7 24 201.4 652 89.8
Tennessee 11 63.3 86 78.2 9,659 1,033.1 1,046 379.8 4 130.6 6,127 141.5 732 941.1 17,667 307.3
Texas 36 44.1 858 69.8 28,404 987.2 42,376 477.0 21 100.2 19,842 192.7 3,652 1,276.2 95,196 402.1
Utah 31 128.9 70 99.6 293 991.8 762 224.8 9 36.9 1,840 91.7 81 186.8 3,089 121.7
Vermont 0 0.0 19 186.9 74 1,115.5 60 579.6 0 0.0 538 106.2 31 374.0 722 132.7
Virginia 19 94.9 344 69.6 13,354 976.2 2,400 378.6 9 164.5 6,504 143.7 1,034 681.8 23,691 329.0
Washington 125 157.2 483 78.2 2,335 937.6 2,265 311.0 57 127.6 7,753 173.4 993 459.8 14,019 218.8
West Virginia 3 88.2 12 95.3 384 719.1 96 405.3 0 0.0 1,368 96.1 119 597.9 1,986 129.2
Wisconsin 25 59.3 95 68.3 2,427 833.9 955 315.3 2 111.1 2,738 67.0 256 405.0 6,499 131.9
Wyoming 11 116.2 4 74.4 19 357.7 64 146.1 0 0.0 236 57.4 11 156.7 345 71.5
Subtotal 3,209 160.9 15,450 94.8 421,778 1,241.9 248,889 529.4 910 185.5 303,487 177.1 48,819 1,005.4 1,043,284 378.0
U.S. dependent arease
American Samoa 0 0 0 0 0 0 1 1 2.6
Guam 0 55 4 9 21 12 6 107 83.8
Northern Mariana Islands 1 5 0 0 6 2 2 16 39.4
Puerto Rico 1 2 21 15,767 1 39 6 15,837 563.3
Republic of Palau 0 2 0 1 6 0 0 9 49.4
U.S. Virgin Islands 0 2 294 189 0 39 3 530 603.2
Subtotal 2 66 319 15,966 34 92 18 16,500 528.2
Total 3,211 15,516 422,097 264,855 944 303,579 48,837 1,059,784 379.7

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Data are based on address of residence at the end of the specified year (i.e., most recent known address). Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
bHispanic/Latino persons can be of any race.
cIncludes persons whose race/ethnicity is unknown.
dRates are per 100,000 population.
eRates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.

Table 22. Diagnoses of HIV infection, 2019, and persons living with diagnosed HIV infection (prevalence), year-end 2019, by metropolitan statistical area of residence—United States and Puerto Rico
Diagnosis, 2019a Prevalence of diagnosed HIV
infection, year-end 2019b
Metropolitan statistical area of residence No. Ratec Rankd No. Ratec
Akron, OH 54 7.7 70 1,047 148.8
Albany-Schenectady-Troy, NY 48 5.5 90 2,166 246.0
Albuquerque, NM 71 7.7 69 1,914 208.5
Allentown-Bethlehem-Easton, PA-NJ 54 6.4 81 1,626 192.6
Atlanta-Sandy Springs-Alpharetta, GA 1,661 27.6 2 38,445 638.6
Augusta-Richmond County, GA-SC 121 19.9 11 2,553 419.2
Austin-Round Rock-Georgetown, TX 242 10.9 51 6,550 294.1
Bakersfield, CA 179 19.9 10 1,785 198.3
Baltimore-Columbia-Towson, MD 405 14.5 25 16,492 589.0
Baton Rouge, LA 201 23.5 4 5,259 615.2
Birmingham-Hoover, AL 143 13.1 34 4,292 393.6
Boise City, ID 19 2.5 109 226 30.2
Boston-Cambridge-Newton, MA-NHe 381 7.8 67 14,507 297.7
Boston, MA 203 10.0 8,270 407.0
Cambridge-Newton-Framingham, MA 172 7.2 5,953 248.0
Bridgeport-Stamford-Norwalk, CT 42 4.5 100 2,705 286.7
Buffalo-Cheektowaga, NY 65 5.8 88 2,548 225.9
Cape Coral-Fort Myers, FL 78 10.1 55 2,218 287.8
Charleston-North Charleston, SC 106 13.2 33 2,703 337.0
Charlotte-Concord-Gastonia, NC-SC 414 15.7 20 9,068 343.9
Chattanooga, TN-GA 60 10.6 52 1,257 222.4
Chicago-Naperville-Elgin, IL-IN-WI 1,118 11.8 43 30,187 319.2
Chicago-Naperville-Evanston, IL 974 13.7 27,390 384.5
Elgin, IL 35 4.6 510 66.6
Gary, IN 63 9.0 1,245 177.0
Lake County-Kenosha County, IL-WI 46 5.3 1,042 120.3
Cincinnati, OH-KY-IN 257 11.6 44 4,631 208.5
Cleveland-Elyria, OH 190 9.3 60 5,580 272.4
Colorado Springs, CO 44 5.9 86 1,016 136.2
Columbia, SC 147 17.5 15 4,212 502.4
Columbus, OH 239 11.3 49 5,977 281.6
Dallas-Fort Worth-Arlington, TX 1,259 16.6 17 29,513 389.7
Dallas-Plano-Irving, TX 939 18.5 23,029 453.2
Fort Worth-Arlington, TX 320 12.8 6,484 260.3
Dayton-Kettering, OH 112 13.9 30 1,771 219.3
Deltona-Daytona Beach-Ormond Beach, FL 98 14.7 23 2,043 305.7
Denver-Aurora-Lakewood, CO 342 11.5 45 9,675 326.1
Des Moines-West Des Moines, IA 29 4.1 103 968 138.4
Detroit-Warren-Dearborn, MI 438 10.1 54 10,562 244.5
Detroit-Dearborn-Livonia, MI 285 16.3 6,960 397.9
Warren-Troy-Farmington Hills, MI 153 6.0 3,602 140.1
Durham-Chapel Hill, NC 93 14.4 26 2,526 392.0
El Paso, TX 116 13.7 32 2,337 276.9
Fayetteville, NC 94 17.8 14 1,939 368.1
Fayetteville-Springdale-Rogers, AR 22 4.1 104 639 119.5
Fresno, CA 115 11.5 46 2,063 206.5
Grand Rapids-Wyoming, MI 53 4.9 94 1,290 119.7
Greensboro-High Point, NC 148 19.2 13 2,940 380.9
Greenville-Anderson, SC 105 11.4 48 2,168 235.5
Harrisburg-Carlisle, PA 33 5.7 89 1,510 261.3
Hartford-East Hartford-Middletown, CT 83 6.9 77 3,546 294.3
Honolulu (Urban), HI 52 5.3 91 1,515 155.5
Houston-The Woodlands-Sugar Land, TX 1,436 20.3 9 27,310 386.5
Indianapolis-Carmel-Anderson, IN 265 12.8 36 5,729 276.2
Jackson, MS 125 21.0 7 3,425 575.8
Jacksonville, FL 317 20.3 8 7,285 467.1
Kansas City, MO-KS 206 9.5 59 4,919 227.9
Knoxville, TN 91 10.5 53 1,333 153.4
Lakeland-Winter Haven, FL 125 17.2 16 2,584 356.5
Lancaster, PA 25 4.6 97 798 146.2
Lansing-East Lansing, MI 24 4.4 101 634 115.2
Las Vegas-Henderson-Paradise, NV 449 19.8 12 9,048 399.2
Lexington-Fayette, KY 33 6.4 82 1,153 223.0
Little Rock-North Little Rock-Conway, AR 123 16.6 18 2,388 321.7
Los Angeles-Long Beach-Anaheim, CA 1,730 13.1 35 56,692 429.0
Anaheim-Santa Ana-Irvine, CA 246 7.7 6,990 220.1
Los Angeles-Long Beach-Glendale, CA 1,484 14.8 49,702 495.1
Louisville/Jefferson County, KY-IN 175 13.8 31 3,726 294.5
Madison, WI 17 2.6 108 820 123.3
McAllen-Edinburg-Mission, TX 57 6.6 80 1,501 172.8
Memphis, TN-MS-AR 310 23.0 5 7,332 544.7
Miami-Fort Lauderdale-Pompano Beach, FL 1,984 32.2 1 54,492 883.7
Fort Lauderdale-Pompano Beach-Sunrise, FL 594 30.4 19,836 1,015.8
Miami-Miami Beach-Kendall, FL 1,152 42.4 26,624 979.9
West Palm Beach-Boca Raton-Boynton Beach, FL 238 15.9 8,032 536.6
Milwaukee-Waukesha, WI 118 7.5 72 3,300 209.5
Minneapolis-St. Paul-Bloomington, MN-WI 227 6.2 83 7,490 205.8
Modesto, CA 42 7.6 71 822 149.3
Nashville-Davidson-Murfreesboro-Franklin, TN 240 12.4 39 5,440 281.2
New Haven-Milford, CT 68 8.0 66 3,325 389.0
New Orleans-Metairie, LA 282 22.2 6 8,141 640.8
New York-Newark-Jersey City, NY-NJ-PAe 2,820 14.7 22 137,245 714.2
Nassau County-Suffolk County, NY 182 6.4 5,858 206.7
Newark, NJ-PA 351 16.2 12,918 595.9
New Brunswick-Lakewood, NJ 192 8.1 5,105 214.5
New York-Jersey City-White Plains, NY-NJ 2,095 17.7 113,364 957.9
North Port-Sarasota-Bradenton, FL 70 8.4 63 2,086 249.2
Ogden-Clearfield, UT 16 2.3 110 415 60.7
Oklahoma City, OK 167 11.9 42 2,884 204.7
Omaha-Council Bluffs, NE-IA 58 6.1 85 519 54.7
Orlando-Kissimmee-Sanford, FL 654 25.1 3 12,622 483.9
Oxnard-Thousand Oaks-Ventura, CA 45 5.3 92 1,100 130.0
Palm Bay-Melbourne-Titusville, FL 85 14.1 28 1,659 275.6
Pensacola-Ferry Pass-Brent, FL 45 9.0 61 1,544 307.2
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 774 12.7 37 26,606 436.0
Camden, NJ 111 8.9 2,978 239.5
Montgomery County-Bucks County-Chester County, PA 85 4.3 2,429 122.4
Philadelphia, PA 514 23.9 18,815 874.8
Wilmington, DE-MD-NJ 64 8.8 2,384 329.3
Phoenix-Mesa-Scottsdale, AZ 591 11.9 40 12,853 259.8
Pittsburgh, PA 105 4.5 99 3,602 155.4
Portland-South Portland, ME 18 3.3 107 892 165.6
Portland-Vancouver-Hillsboro, OR-WA 169 6.8 78 5,705 228.9
Poughkeepsie-Newburgh-Middletown, NY 50 7.4 73 1,851 272.5
Providence-Warwick, RI-MA 101 6.2 84 3,137 193.1
Provo-Orem, UT 23 3.5 106 245 37.8
Raleigh-Cary, NC 159 11.4 47 3,995 287.2
Richmond, VA 103 8.0 65 3,547 274.6
Riverside-San Bernardino-Ontario, CA 555 11.9 41 14,187 305.1
Rochester, NY 56 5.2 93 2,813 263.0
Sacramento-Roseville-Folsom, CA 171 7.2 75